<SEC-DOCUMENT>0000914121-22-004125.txt : 20221021
<SEC-HEADER>0000914121-22-004125.hdr.sgml : 20221021
<ACCEPTANCE-DATETIME>20221021095059
ACCESSION NUMBER:		0000914121-22-004125
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20221021
DATE AS OF CHANGE:		20221021
GROUP MEMBERS:		POLITAN CAPITAL MANAGEMENT GP LLC
GROUP MEMBERS:		POLITAN CAPITAL PARTNERS GP LLC
GROUP MEMBERS:		QUENTIN KOFFEY

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MASIMO CORP
		CENTRAL INDEX KEY:			0000937556
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				330368882
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0101

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-83497
		FILM NUMBER:		221322434

	BUSINESS ADDRESS:	
		STREET 1:		52 DISCOVERY
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92618
		BUSINESS PHONE:		949-297-7000

	MAIL ADDRESS:	
		STREET 1:		52 DISCOVERY
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92618

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Politan Capital Management LP
		CENTRAL INDEX KEY:			0001885245
		IRS NUMBER:				871666292
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		C/O SCHULTE ROTH & ZABEL LLP
		STREET 2:		919 THIRD AVENUE, SUITE 2300
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		(212) 756-2000

	MAIL ADDRESS:	
		STREET 1:		C/O SCHULTE ROTH & ZABEL LLP
		STREET 2:		919 THIRD AVENUE, SUITE 2300
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>po58315551-sc13da2.htm
<DESCRIPTION>SCHEDULE 13D (AMENDMENT NO. 2)
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Cadwalader
         Document created using Broadridge PROfile 22.10.1.5080
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; text-align: left; color: #000000;">
  <div><br>
  </div>
  <div>
    <div style="margin-bottom: 2pt;"><br>
    </div>
    <div style="margin-bottom: 2pt;">
      <div style="line-height: 14.4pt; border-bottom: 1.5pt double black;">
        <div style="line-height: 10pt; margin-bottom: 2pt;"><br style="line-height: 10pt;">
        </div>
        <div style="line-height: 0pt;"><br style="line-height: 0pt;">
        </div>
      </div>
      <div style="text-align: center; line-height: 15.95pt; margin-top: 12pt; color: #000000; font-size: 14pt; font-weight: bold;">UNITED STATES</div>
      <div style="text-align: center; line-height: 15.95pt; color: #000000; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
      <div style="text-align: center; line-height: 11.4pt; margin-bottom: 12pt; color: #000000; font-weight: bold;">Washington, D.C. 20549</div>
      <div style="text-align: center; line-height: 13.7pt; font-size: 12pt;"><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u></div>
      <div style="text-align: center; line-height: 20.5pt; margin-top: 12pt; color: #000000; font-size: 18pt; font-weight: bold;">SCHEDULE 13D</div>
      <div style="text-align: center; line-height: 11.4pt; color: #000000; font-weight: bold;">(Rule 13d-101)</div>
      <div style="text-align: center; line-height: 11.4pt; margin-top: 12pt; color: #000000; font-weight: bold;">INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT</div>
      <div style="text-align: center; line-height: 11.4pt; color: #000000; font-weight: bold;">TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED</div>
      <div style="text-align: center; line-height: 11.4pt; color: #000000; font-weight: bold;">PURSUANT TO RULE 13d-2(a)</div>
      <div style="text-align: center; line-height: 11.4pt; margin-top: 6pt; color: #000000; font-weight: bold;">Under the Securities Exchange Act of 1934</div>
      <div style="text-align: center; line-height: 11.4pt; margin-top: 6pt; color: #000000; font-weight: bold;">(Amendment No. 2)*</div>
      <div style="text-align: center; line-height: 20.5pt; margin-top: 9pt; color: #000000; font-size: 18pt; font-weight: bold;">Masimo Corporation</div>
      <div style="text-align: center; line-height: 11.4pt; color: #000000; font-weight: bold;">(Name of Issuer)</div>
      <div style="text-align: center; line-height: 11.4pt; margin-top: 12pt; color: #000000; font-weight: bold;">Common Stock, par value $0.001 per share</div>
      <div style="text-align: center; line-height: 11.4pt; color: #000000; font-weight: bold;">(Title of Class of Securities)</div>
      <div style="text-align: center; line-height: 11.4pt; margin-top: 12pt; color: #000000; font-weight: bold;">574795100</div>
      <div style="text-align: center; line-height: 11.4pt; color: #000000; font-weight: bold;">(CUSIP Number)</div>
      <div style="text-align: center; line-height: 11.4pt; margin-top: 6pt; color: #000000; font-weight: bold;">Quentin Koffey</div>
      <div style="text-align: center; line-height: 11.4pt; color: #000000; font-weight: bold;">Politan Capital Management LP</div>
      <div style="text-align: center; line-height: 11.4pt; color: #000000; font-weight: bold;">c/o Schulte Roth &amp; Zabel LLP</div>
      <div style="text-align: center; line-height: 11.4pt; color: #000000; font-weight: bold;">919 Third Avenue, Suite 2300</div>
      <div style="text-align: center; line-height: 11.4pt; color: #000000; font-weight: bold;">New York, New York 10022</div>
      <div style="text-align: center; line-height: 11.4pt; color: #000000; font-weight: bold;">646-690-2830</div>
      <div style="text-align: center; line-height: 11.4pt; margin-top: 6pt; color: #000000; font-style: italic; font-weight: bold;">With a copy to:</div>
      <div style="text-align: center; line-height: 11.4pt; margin-top: 6pt; color: #000000; font-weight: bold;">Richard M. Brand</div>
      <div style="text-align: center; line-height: 11.4pt; color: #000000; font-weight: bold;">Cadwalader, Wickersham &amp; Taft LLP</div>
      <div style="text-align: center; line-height: 11.4pt; color: #000000; font-weight: bold;">200 Liberty Street</div>
      <div style="text-align: center; line-height: 11.4pt; color: #000000; font-weight: bold;">New York, NY 10281</div>
      <div style="text-align: center; line-height: 11.4pt; color: #000000; font-weight: bold;">212-504-6000</div>
      <div style="text-align: center; line-height: 11.4pt; color: #000000; font-weight: bold;">(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)</div>
      <div style="text-align: center; line-height: 11.4pt; margin-top: 9pt; color: #000000; font-weight: bold;">October 21, 2022</div>
      <div style="text-align: center; line-height: 11.4pt; color: #000000; font-weight: bold;">(Date of Event Which Requires Filing of This Statement)</div>
      <div style="text-align: center; line-height: 13.7pt; font-size: 12pt;"><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u></div>
      <div style="text-align: center; line-height: 10.25pt; margin-top: 6pt; margin-bottom: 6pt; color: #000000;">If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and
        is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. &#9744;</div>
      <div style="line-height: 14.4pt; border-top: 0.75pt solid; border-bottom: 0.75pt solid;">
        <div style="line-height: 10.25pt; color: #000000;"><font style="font-weight: bold;">Note:</font> Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other
          parties to whom copies are to be sent.</div>
      </div>
      <div style="line-height: 10.25pt;"><br style="line-height: 10.25pt;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z5337baab44584f34b9b8aac9e2209040" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 2%; vertical-align: top;">
              <div style="line-height: 10.25pt; color: #000000;">&#160;*</div>
            </td>
            <td style="width: 98%; vertical-align: top;">
              <div style="line-height: 10.25pt; color: #000000;">The remainder of this cover page shall be filled out for a reporting person&#8217;s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment
                containing information which would alter disclosures provided in a prior cover page.</div>
            </td>
          </tr>

      </table>
      <div style="text-indent: 17.3pt; line-height: 10.25pt; margin-top: 6pt; color: #000000;">The information required on the remainder of this cover page shall not be deemed to be &#8220;filed&#8221; for the purpose of section 18 of the Securities Exchange Act of
        1934 (&#8220;Act&#8221;) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).</div>
      <div style="line-height: 10.25pt; margin-top: 6pt; color: rgb(0, 0, 0);"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 0pt;"><br style="line-height: 0pt;">
      </div>
      <div style="line-height: 10pt; margin-bottom: 2pt;"><br style="line-height: 10pt;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z4d245ad9aaa447f2bf7566838e704829" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 11.4pt; color: #000000;">CUSIP No. 574795100</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
            </td>
            <td style="width: 49%; vertical-align: bottom;">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">Page 2</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <table cellspacing="0" cellpadding="3" border="0" id="zecdaa5df2a064e58ae9a77f7ba79c7fe" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">1</div>
            </td>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">NAME OF REPORTING PERSON</div>
              <div style="line-height: 11.4pt; color: #000000;">Politan Capital Management LP</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">2</div>
            </td>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</div>
              <div style="line-height: 11.4pt; color: #000000;">(a) &#9746;&#160; (b) &#9744;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">3</div>
            </td>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">SEC USE ONLY</div>
              <div style="line-height: 11.4pt;"><font style="line-height: 11.4pt;">&#160;</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">4</div>
            </td>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">SOURCE OF FUNDS</div>
              <div style="line-height: 11.4pt;"><font style="line-height: 11.4pt;">&#160;</font></div>
              <div style="line-height: 11.4pt; color: #000000;">OO (See Item 3)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">5</div>
            </td>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)</div>
              <div style="line-height: 11.4pt;"><font style="line-height: 11.4pt;">&#160;</font></div>
              <div style="line-height: 11.4pt; color: #000000;">&#9744;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">6</div>
            </td>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">CITIZENSHIP OR PLACE OF ORGANIZATION</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">Delaware</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: middle; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" rowspan="4" colspan="2">
              <div style="text-align: center; line-height: 11.4pt; color: #000000;">Number of<br>
                shares<br>
                beneficially<br>
                owned by<br>
                each<br>
                reporting<br>
                person<br>
                with</div>
            </td>
            <td style="width: 5%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">7</div>
            </td>
            <td style="width: 82%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">SOLE VOTING POWER</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">0</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">8</div>
            </td>
            <td style="width: 82%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">SHARED VOTING POWER</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">4,648,869</div>
              <div style="line-height: 11.4pt;"><font style="line-height: 11.4pt;">&#160;</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">9</div>
            </td>
            <td style="width: 82%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">SOLE DISPOSITIVE POWER</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">0</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">10</div>
            </td>
            <td style="width: 82%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">SHARED DISPOSITIVE POWER</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">4,648,869</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">11</div>
            </td>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">4,648,869</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">12</div>
            </td>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">&#9744;</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">13</div>
            </td>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">8.8%*</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">14</div>
            </td>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">TYPE OF REPORTING PERSON</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">IA</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 9.1pt; margin-top: 6pt; color: #000000; font-size: 8pt;">* All percentage calculations set forth herein are based upon the aggregate of 52,530,244 shares of Common Stock outstanding as of July 2, 2022, as
        reported in the Issuer&#8217;s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the &#8220;<u>SEC</u>&#8221;) on August 10, 2022.</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zbf4824f4852c4ce4a5de14447ecc5a7c" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 11.4pt; color: #000000;">CUSIP No. 574795100</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
            </td>
            <td style="width: 49%; vertical-align: bottom;">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">Page 3</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 11.4pt; margin-bottom: 8pt;"><br style="line-height: 11.4pt;">
      </div>
      <table cellspacing="0" cellpadding="3" border="0" id="z8d673744515a44278d2ef325d2170c92" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">1</div>
            </td>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">NAME OF REPORTING PERSON</div>
              <div style="line-height: 11.4pt; color: #000000;">Politan Capital Management GP LLC</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">2</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</div>
              <div style="line-height: 11.4pt; color: #000000;">(a) &#9746;&#160; (b) &#9744;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">3</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">SEC USE ONLY</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt;"><font style="line-height: 11.4pt;">&#160;</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">4</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">SOURCE OF FUNDS</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">OO (See Item 3)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">5</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)</div>
              <div style="line-height: 11.4pt;"><font style="line-height: 11.4pt;">&#160;</font></div>
              <div style="line-height: 11.4pt; color: #000000;">&#9744;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">6</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">CITIZENSHIP OR PLACE OF ORGANIZATION</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">Delaware</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: middle; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" rowspan="4" colspan="2">
              <div style="text-align: center; line-height: 11.4pt; color: #000000;">Number of<br>
                shares<br>
                beneficially<br>
                owned by<br>
                each<br>
                reporting<br>
                person<br>
                with</div>
            </td>
            <td style="width: 5%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">7</div>
            </td>
            <td style="width: 82%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">SOLE VOTING POWER</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">0</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">8</div>
            </td>
            <td style="width: 82%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">SHARED VOTING POWER</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">4,648,869</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">9</div>
            </td>
            <td style="width: 82%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">SOLE DISPOSITIVE POWER</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">0</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">10</div>
            </td>
            <td style="width: 82%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">SHARED DISPOSITIVE POWER</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">4,648,869</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">11</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">4,648,869</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">12</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">&#9744;</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">13</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">8.8%*</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">14</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">TYPE OF REPORTING PERSON</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">IA</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 9.1pt; color: #000000; font-size: 8pt;">* All percentage calculations set forth herein are based upon the aggregate of 52,530,244 shares of Common Stock outstanding as of July 2, 2022, as reported in the
        Issuer&#8217;s Quarterly Report on Form 10-Q filed with the SEC on August 10, 2022.</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="ze5f4e7b1ec994e02b2aeacd3efb5fb68" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 11.4pt; color: #000000;">CUSIP No. 574795100</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
            </td>
            <td style="width: 49%; vertical-align: bottom;">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">Page 4</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 11.4pt; margin-bottom: 8pt;"><br style="line-height: 11.4pt;">
      </div>
      <table cellspacing="0" cellpadding="3" border="0" id="zaaa2deece8694dec86ff48b41801f859" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">1</div>
            </td>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">NAME OF REPORTING PERSON</div>
              <div style="line-height: 11.4pt; color: #000000;">Politan Capital Partners GP LLC</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">2</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</div>
              <div style="line-height: 11.4pt; color: #000000;">(a) &#9746;&#160; (b) &#9744;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">3</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">SEC USE ONLY</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt;"><font style="line-height: 11.4pt;">&#160;</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">4</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">SOURCE OF FUNDS</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">OO (See Item 3)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">5</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)</div>
              <div style="line-height: 11.4pt;"><font style="line-height: 11.4pt;">&#160;</font></div>
              <div style="line-height: 11.4pt; color: #000000;">&#9744;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">6</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">CITIZENSHIP OR PLACE OF ORGANIZATION</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">Delaware</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: middle; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" rowspan="4" colspan="2">
              <div style="text-align: center; line-height: 11.4pt; color: #000000;">Number of<br>
                shares<br>
                beneficially<br>
                owned by<br>
                each<br>
                reporting<br>
                person<br>
                with</div>
            </td>
            <td style="width: 5%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">7</div>
            </td>
            <td style="width: 82%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">SOLE VOTING POWER</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">0</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">8</div>
            </td>
            <td style="width: 82%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">SHARED VOTING POWER</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">4,648,869</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">9</div>
            </td>
            <td style="width: 82%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">SOLE DISPOSITIVE POWER</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">0</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">10</div>
            </td>
            <td style="width: 82%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">SHARED DISPOSITIVE POWER</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">4,648,869</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">11</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">4,648,869</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">12</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">&#9744;</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">13</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">8.8%*</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">14</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">TYPE OF REPORTING PERSON</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">IA</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 9.1pt; color: #000000; font-size: 8pt;">* All percentage calculations set forth herein are based upon the aggregate of 52,530,244 shares of Common Stock outstanding as of July 2, 2022, as reported in the
        Issuer&#8217;s Quarterly Report on Form 10-Q filed with the SEC on August 10, 2022.</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zd311f3a0bb5b4d11a2a79d38c315ed44" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 11.4pt; color: #000000;">CUSIP No. 574795100</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
            </td>
            <td style="width: 49%; vertical-align: bottom;">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">Page 5</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 11.4pt; margin-bottom: 8pt;"><br style="line-height: 11.4pt;">
      </div>
      <table cellspacing="0" cellpadding="3" border="0" id="z632d78d9148941968a5f9b36ce0878e0" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">1</div>
            </td>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">NAME OF REPORTING PERSON</div>
              <div style="line-height: 11.4pt; color: #000000;">Quentin Koffey</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">2</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</div>
              <div style="line-height: 11.4pt; color: #000000;">(a) &#9746;&#160; (b) &#9744;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">3</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">SEC USE ONLY</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt;"><font style="line-height: 11.4pt;">&#160;</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">4</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">SOURCE OF FUNDS</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">OO (See Item 3)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">5</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)</div>
              <div style="line-height: 11.4pt;"><font style="line-height: 11.4pt;">&#160;</font></div>
              <div style="line-height: 11.4pt; color: #000000;">&#9744;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">6</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 11.4pt; color: #000000;">CITIZENSHIP OR PLACE OF ORGANIZATION</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">United States</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: middle; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" rowspan="4" colspan="2">
              <div style="text-align: center; line-height: 11.4pt; color: #000000;">Number of<br>
                shares<br>
                beneficially<br>
                owned by<br>
                each<br>
                reporting<br>
                person<br>
                with</div>
            </td>
            <td style="width: 5%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">7</div>
            </td>
            <td style="width: 82%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">SOLE VOTING POWER</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">0</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">8</div>
            </td>
            <td style="width: 82%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">SHARED VOTING POWER</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">4,648,869</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">9</div>
            </td>
            <td style="width: 82%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">SOLE DISPOSITIVE POWER</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">0</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">10</div>
            </td>
            <td style="width: 82%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="line-height: 11.4pt; color: #000000;">SHARED DISPOSITIVE POWER</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">4,648,869</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">11</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">4,648,869</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">12</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">&#9744;</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">13</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">8.8%*</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">14</div>
            </td>
            <td style="vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 11.4pt; color: #000000;">TYPE OF REPORTING PERSON</div>
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
              <div style="line-height: 11.4pt; color: #000000;">IN</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 9.1pt; color: #000000; font-size: 8pt;">* All percentage calculations set forth herein are based upon the aggregate of 52,530,244 shares of Common Stock outstanding as of July 2, 2022, as reported in the
        Issuer&#8217;s Quarterly Report on Form 10-Q filed with the SEC on August 10, 2022.</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z28cac3ae5b5e4401b9a7a61bf611d074" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 11.4pt; color: #000000;">CUSIP No. 574795100</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
            </td>
            <td style="width: 49%; vertical-align: bottom;">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">Page 6</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 36pt; line-height: 11.4pt; margin-top: 12pt; color: #000000;">This Amendment No. 2 to Schedule 13D (this &#8220;<u>Amendment No. 2</u>&#8221;) amends and supplements the Schedule 13D filed on August 16, 2022 (as
        amended and supplemented through the date of this Amendment No. 2, collectively, the &#8220;<u>Schedule 13D</u>&#8221;) by the Reporting Persons, relating to the common stock, par value $0.001 per share, of Masimo Corporation, a Delaware corporation (the &#8220;<u>Issuer</u>&#8221;).

        Capitalized terms not defined in this Amendment No. 2 shall have the meaning ascribed to them in the Schedule 13D.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 11.4pt; margin-top: 12pt; margin-bottom: 12pt; color: #000000;">The information set forth in response to Item 4 below shall be deemed to be a response to all Items where such
        information is relevant.</div>
      <table cellspacing="0" cellpadding="0" id="z221dc0e884dd4900b857c7b9f25d9731" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 100%; vertical-align: top;">
              <div style="line-height: 11.4pt; color: #000000; font-weight: bold;">ITEM 4.&#160;&#160; PURPOSE OF TRANSACTION</div>
              <div style="text-indent: 36pt; line-height: 11.4pt;"> <br>
              </div>
              <div style="text-indent: 36pt; line-height: 11.4pt;">Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following information:</div>
              <div style="text-indent: 36pt; line-height: 11.4pt;"> <br>
              </div>
              <div style="text-align: justify; text-indent: 36pt; line-height: 11.4pt;">On October 21, 2022, Politan has filed a Verified Complaint (the &#8220;Complaint&#8221;) in the Delaware Court of Chancery against the Issuer and the members of the Issuer&#8217;s Board
                of Directors (the &#8220;Director Defendants&#8221;) seeking relief to (i) declare the amendments to certain of the Issuer&#8217;s corporate bylaws unenforceable, (ii) find that the Director Defendants breached their fiduciary duties, (iii) invalidate
                certain change of control provisions in the Issuer&#8217;s CEO Joe Kiani&#8217;s employment agreement, and (iv) permanently enjoin the Issuer and its Board of Directors from taking any actions to prevent Politan from exercising its rights in accordance
                with the Issuer&#8217;s prior corporate bylaws to nominate directors, as more fully described in the Complaint.</div>
              <div style="text-align: justify; text-indent: 36pt; line-height: 11.4pt;"> <br>
              </div>
              <div style="text-align: justify; text-indent: 36pt; line-height: 11.4pt;">The foregoing description of the Complaint does not purport to be complete and is qualified in its entirety by reference to the full text of the Complaint, which is
                attached hereto as Exhibit 99.4 and is incorporated herein by reference.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zefac967af2494f03ab47d38da04c8ccc" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 11.4pt; color: #000000;">CUSIP No. 574795100</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
            </td>
            <td style="width: 49%; vertical-align: bottom;">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">Page 7</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zc6be5ed19a7f42f3b29ea86876c443ac" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 8.2%; vertical-align: top;">
              <div style="line-height: 11.4pt; color: #000000; font-weight: bold;">ITEM 7.</div>
            </td>
            <td style="width: 91.8%; vertical-align: top;">
              <div style="line-height: 11.4pt; color: #000000; font-weight: bold;">MATERIAL TO BE FILED AS AN EXHIBIT</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zdf42a3eb082b4951a680d207d76f6f01" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 13.7%; vertical-align: top;">
              <div style="line-height: 11.4pt; color: #000000;">Exhibit 99.1</div>
            </td>
            <td style="width: 86.3%; vertical-align: top;">
              <div style="line-height: 11.4pt; color: #000000;">Joint Filing Agreement among Politan Capital Management LP, Politan Capital Management GP LLC, Politan Capital Partners GP LLC, and Quentin Koffey*</div>
            </td>
          </tr>
          <tr>
            <td style="width: 13.7%; vertical-align: top;">
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
            </td>
            <td style="width: 86.3%; vertical-align: top;">
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 13.7%; vertical-align: top;">
              <div style="line-height: 11.4pt; color: #000000;">Exhibit 99.2</div>
            </td>
            <td style="width: 86.3%; vertical-align: top;">
              <div style="line-height: 11.4pt; color: #000000;">Trading Data*</div>
              <div style="line-height: 11.4pt;"><font style="line-height: 11.4pt;">&#160;</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 13.7%; vertical-align: top;">
              <div style="line-height: 11.4pt; color: #000000;">Exhibit 99.3</div>
              <div style="line-height: 11.4pt;"><font style="line-height: 11.4pt;">&#160;</font></div>
              <div style="line-height: 11.4pt; color: #000000;">Exhibit <a href="po58315551-ex99_4.htm">99.4</a></div>
            </td>
            <td style="width: 86.3%; vertical-align: top;">
              <div style="line-height: 11.4pt; color: #000000;">Trading Data*</div>
              <div style="line-height: 11.4pt;"><font style="line-height: 11.4pt;">&#160;</font></div>
              <div style="line-height: 11.4pt; color: #000000;">Form of Verified Complaint, filed with the Delaware Court of Chancery on October 21, 2022.</div>
              <div style="line-height: 11.4pt;"><font style="line-height: 11.4pt;">&#160;</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 13.7%; vertical-align: top;">&#160;</td>
            <td style="width: 86.3%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt; color: #000000;">*Previously filed.</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zf4c977a4a16543c297824f66705542e3" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 11.4pt; color: #000000;">CUSIP No. 574795100</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
            </td>
            <td style="width: 49%; vertical-align: bottom;">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">Page 8</div>
            </td>
          </tr>

      </table>
      <div style="text-align: center; line-height: 11.4pt; margin-top: 24pt; color: #000000;">SIGNATURES</div>
      <div style="text-indent: 36pt; line-height: 11.4pt; margin-top: 12pt; color: #000000;">After reasonable inquiry and to the best of each of the undersigned&#8217;s knowledge and belief, each of the undersigned certify that the information set forth in this
        statement is true, complete and correct.</div>
      <div style="line-height: 11.4pt; margin-top: 12pt; color: #000000;">Date: October 21, 2022</div>
      <div style="line-height: 11.4pt; margin-top: 12pt; color: #000000;">
        <div style="text-indent: 36pt; margin-top: 12pt;">
          <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: Arial, Helvetica, sans-serif; font-size: 10pt;">

              <tr>
                <td valign="top" style="width: 50%;">&#160;</td>
                <td valign="top" colspan="2" style="width: 38%;">POLITAN CAPITAL MANAGEMENT LP</td>
                <td valign="top" style="width: 12%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%;">&#160;</td>
                <td valign="top" style="width: 3%;">&#160;</td>
                <td valign="top" style="width: 35%;">&#160;</td>
                <td valign="top" style="width: 12%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" rowspan="1" style="width: 50%;">&#160;</td>
                <td valign="top" rowspan="1" style="width: 3%;">By:<br>
                </td>
                <td valign="top" rowspan="1" style="width: 35%;">Politan Capital Management GP LLC, its general partner</td>
                <td valign="top" rowspan="1" style="width: 12%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" rowspan="1" style="width: 50%;">&#160;</td>
                <td valign="top" rowspan="1" style="width: 3%;">&#160;</td>
                <td valign="top" rowspan="1" style="width: 35%;">&#160;</td>
                <td valign="top" rowspan="1" style="width: 12%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;">
                  <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt"><br>
                  </div>
                </td>
                <td valign="top" style="width: 3%; padding-bottom: 2px;">
                  <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
                </td>
                <td valign="top" nowrap="nowrap" align="left" style="width: 35%; border-bottom: 2px solid rgb(0, 0, 0);">/s/&#160; Quentin Koffey<br>
                </td>
                <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%;">&#160;</td>
                <td valign="top" style="width: 3%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" align="left" style="width: 35%;">Name:&#160; Quentin Koffey<br>
                </td>
                <td valign="top" style="width: 12%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%;">&#160;</td>
                <td valign="top" style="width: 3%;">&#160;</td>
                <td valign="top" style="width: 35%;">Title:&#160; &#160;&#160; Managing Member</td>
                <td valign="top" style="width: 12%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%;">&#160;</td>
                <td valign="top" style="width: 3%;">&#160;</td>
                <td valign="top" style="width: 35%;">&#160;</td>
                <td valign="top" style="width: 12%;">&#160;</td>
              </tr>

          </table>
        </div>
        <div style="margin-top: 12pt;">
          <div style="text-indent: 36pt; margin-top: 12pt;">
            <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: Arial, Helvetica, sans-serif; font-size: 10pt;">

                <tr>
                  <td valign="top" style="width: 50%;">&#160;</td>
                  <td valign="top" colspan="2" style="width: 38%;">POLITAN CAPITAL MANAGEMENT GP LLC</td>
                  <td valign="top" style="width: 12%;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" rowspan="1" style="width: 50%;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 3%;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 35%;">&#160;</td>
                  <td valign="top" rowspan="1" style="width: 12%;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;">
                    <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt"><br>
                    </div>
                  </td>
                  <td valign="top" style="width: 3%; padding-bottom: 2px;">
                    <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
                  </td>
                  <td valign="top" nowrap="nowrap" align="left" style="width: 35%; border-bottom: #000000 2px solid">/s/&#160; Quentin Koffey<br>
                  </td>
                  <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" style="width: 50%;">&#160;</td>
                  <td valign="top" style="width: 3%;">&#160;</td>
                  <td valign="bottom" nowrap="nowrap" align="left" style="width: 35%;">Name:&#160; Quentin Koffey<br>
                  </td>
                  <td valign="top" style="width: 12%;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" style="width: 50%;">&#160;</td>
                  <td valign="top" style="width: 3%;">&#160;</td>
                  <td valign="top" style="width: 35%;">Title:&#160; &#160;&#160; Managing Member</td>
                  <td valign="top" style="width: 12%;">&#160;</td>
                </tr>
                <tr>
                  <td valign="top" style="width: 50%;">&#160;</td>
                  <td valign="top" style="width: 3%;">&#160;</td>
                  <td valign="top" style="width: 35%;">&#160;</td>
                  <td valign="top" style="width: 12%;">&#160;</td>
                </tr>

            </table>
          </div>
        </div>
        <div style="margin-top: 12pt;">
          <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: Arial, Helvetica, sans-serif; font-size: 10pt;">

              <tr>
                <td valign="top" style="width: 50%;">&#160;</td>
                <td valign="top" colspan="2" style="width: 38%;">POLITAN CAPITAL PARTNERS GP LLC</td>
                <td valign="top" style="width: 12%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" rowspan="1" style="width: 50%;">&#160;</td>
                <td valign="top" rowspan="1" style="width: 3%;">&#160;</td>
                <td valign="top" rowspan="1" style="width: 35%;">&#160;</td>
                <td valign="top" rowspan="1" style="width: 12%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;">
                  <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt"><br>
                  </div>
                </td>
                <td valign="top" style="width: 3%; padding-bottom: 2px;">
                  <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
                </td>
                <td valign="top" nowrap="nowrap" align="left" style="width: 35%; border-bottom: #000000 2px solid">/s/&#160; Quentin Koffey<br>
                </td>
                <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%;">&#160;</td>
                <td valign="top" style="width: 3%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" align="left" style="width: 35%;">Name:&#160; Quentin Koffey<br>
                </td>
                <td valign="top" style="width: 12%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%;">&#160;</td>
                <td valign="top" style="width: 3%;">&#160;</td>
                <td valign="top" style="width: 35%;">Title:&#160; &#160;&#160; Managing Member</td>
                <td valign="top" style="width: 12%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%;">&#160;</td>
                <td valign="top" style="width: 3%;">&#160;</td>
                <td valign="top" style="width: 35%;">&#160;</td>
                <td valign="top" style="width: 12%;">&#160;</td>
              </tr>

          </table>
        </div>
        <div style="margin-top: 12pt;">
          <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; border-collapse: separate; font-family: Arial, Helvetica, sans-serif; font-size: 10pt;">

              <tr>
                <td valign="top" style="width: 50%;">&#160;</td>
                <td valign="top" colspan="2" style="width: 38%;">QUENTIN KOFFEY</td>
                <td valign="top" style="width: 12%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" rowspan="1" style="width: 50%;">&#160;</td>
                <td valign="top" rowspan="1" style="width: 3%;">&#160;</td>
                <td valign="top" rowspan="1" style="width: 35%;">&#160;</td>
                <td valign="top" rowspan="1" style="width: 12%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" align="left" style="width: 50%; padding-bottom: 2px;">
                  <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt"><br>
                  </div>
                </td>
                <td valign="top" style="width: 3%; padding-bottom: 2px;">
                  <div align="left" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt">By: </div>
                </td>
                <td valign="top" nowrap="nowrap" align="left" style="width: 35%; border-bottom: #000000 2px solid">/s/&#160; Quentin Koffey<br>
                </td>
                <td valign="top" style="width: 12%; padding-bottom: 2px;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%;">&#160;</td>
                <td valign="top" style="width: 3%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" align="left" style="width: 35%;">Name:&#160; Quentin Koffey<br>
                </td>
                <td valign="top" style="width: 12%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%;">&#160;</td>
                <td valign="top" style="width: 3%;">&#160;</td>
                <td valign="top" style="width: 35%;"><br>
                </td>
                <td valign="top" style="width: 12%;">&#160;</td>
              </tr>
              <tr>
                <td valign="top" style="width: 50%;">&#160;</td>
              </tr>

          </table>
        </div>
      </div>
      <div><br>
      </div>
      <br>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z831e6dd685c54e52a8c0031843fa04f3" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 11.4pt; color: #000000;">CUSIP No. 574795100</div>
            </td>
            <td style="width: 1%; vertical-align: bottom;">
              <div style="line-height: 11.4pt; color: #000000;">&#160;</div>
            </td>
            <td style="width: 49%; vertical-align: bottom;">
              <div style="text-align: right; line-height: 11.4pt; color: #000000;">Page 9</div>
            </td>
          </tr>

      </table>
      <div style="text-align: center; line-height: 11.4pt; margin-top: 12pt; margin-bottom: 12pt; color: #000000; font-weight: bold;">INDEX TO EXHIBITS</div>
      <table cellspacing="0" cellpadding="0" id="z7df99c2023df4ce0b76769d978cf0db6" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 13.7%; vertical-align: top;">
              <div style="line-height: 14.4pt; border-bottom: 0.5pt solid black;">
                <div style="line-height: 0pt;"><font style="line-height: 0pt;">&#160;</font></div>
                <div style="line-height: 11.4pt;">Exhibit</div>
              </div>
            </td>
            <td style="width: 1.71%; vertical-align: top;">&#160;</td>
            <td style="width: 83.06%; vertical-align: top;">
              <div style="line-height: 14.4pt; border-bottom: 0.5pt solid black;">
                <div style="line-height: 0pt;"><font style="line-height: 0pt;">&#160;</font></div>
                <div style="text-align: center; line-height: 11.4pt;">Description</div>
              </div>
            </td>
            <td style="width: 1.53%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 13.7%; vertical-align: top;" rowspan="1">Exhibit 99.1</td>
            <td style="width: 1.71%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 83.06%; vertical-align: top;" rowspan="1">
              <div style="line-height: 11.4pt; color: #000000;">Joint Filing Agreement among Politan Capital Management LP, Politan Capital Management GP LLC, Politan Capital Partners GP LLC, and Quentin Koffey*</div>
            </td>
            <td style="width: 1.53%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 13.7%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 1.71%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 83.06%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 1.53%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 13.7%; vertical-align: top;" rowspan="1">Exhibit 99.2</td>
            <td style="width: 1.71%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 83.06%; vertical-align: top;" rowspan="1">Trading Data*</td>
            <td style="width: 1.53%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 13.7%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 1.71%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 83.06%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 1.53%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 13.7%; vertical-align: top;" rowspan="1">Exhibit 99.3</td>
            <td style="width: 1.71%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 83.06%; vertical-align: top;" rowspan="1">
              <div style="line-height: 11.4pt; color: #000000;">Trading Data*</div>
            </td>
            <td style="width: 1.53%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 13.7%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 1.71%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 83.06%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 1.53%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 13.7%; vertical-align: top;" rowspan="1"><font style="color: #000000;">Exhibit <a href="po58315551-ex99_4.htm">99.4</a></font></td>
            <td style="width: 1.71%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 83.06%; vertical-align: top;" rowspan="1"><font style="color: #000000;">Form of Verified Complaint, filed with the Delaware Court of Chancery on October 21, 2022.</font></td>
            <td style="width: 1.53%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt; color: #000000;">*Previously filed.</div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
      <div style="line-height: 11.4pt;"><br style="line-height: 11.4pt;">
      </div>
    </div>
    <div style="margin-bottom: 2pt;"> <br>
    </div>
    <div style="margin-bottom: 2pt;"> <br>
    </div>
    <div style="margin-bottom: 2pt;"> <br>
    </div>
    <div style="margin-bottom: 2pt;"> <br>
    </div>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>po58315551-ex99_4.htm
<DESCRIPTION>FORM OF VERIFIED COMPLAINT
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Cadwalader
         Document created using Broadridge PROfile 22.10.1.5080
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; text-align: left; color: #000000;">
  <div><br>
  </div>
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.4</font><br>
  </div>
  <div> <br>
  </div>
  <div><br>
    <div style="text-align: center; line-height: 15.95pt; margin-bottom: 12pt; font-size: 14pt; font-weight: bold;">IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE</div>
    <table cellspacing="0" cellpadding="0" id="z8d3b8cbe931a4901aa7d26b0456059d3" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 49.22%; vertical-align: top;">
            <div style="line-height: 15.95pt; font-size: 14pt;">POLITAN CAPITAL</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">MANAGEMENT LP, a Delaware </div>
            <div style="line-height: 15.95pt; font-size: 14pt;">limited partnership, and POLITAN </div>
            <div style="line-height: 15.95pt; font-size: 14pt;">CAPITAL NY LLC,</div>
            <div style="line-height: 15.95pt;"><font style="line-height: 15.95pt;">&#160;</font></div>
            <div style="margin-left: 108pt; line-height: 15.95pt; font-size: 14pt;">Plaintiffs,</div>
            <div style="line-height: 15.95pt;"><font style="line-height: 15.95pt;">&#160;</font></div>
            <div style="margin-left: 36pt; line-height: 15.95pt; font-size: 14pt;">v.</div>
            <div style="line-height: 15.95pt;"><font style="line-height: 15.95pt;">&#160;</font></div>
            <div style="line-height: 15.95pt; font-size: 14pt;">JOE E. KIANI, H. MICHAEL COHEN, </div>
            <div style="line-height: 15.95pt; font-size: 14pt;">ADAM P. MIKKELSON, CRAIG B. </div>
            <div style="line-height: 15.95pt; font-size: 14pt;">REYNOLDS, JULIE A. SHIMER, </div>
            <div style="line-height: 15.95pt; font-size: 14pt;">PH.D., and MASIMO CORPORATION, </div>
            <div style="line-height: 15.95pt; font-size: 14pt;">a Delaware corporation,</div>
            <div style="line-height: 15.95pt;"><font style="line-height: 15.95pt;">&#160;</font></div>
            <div style="margin-left: 108pt; line-height: 15.95pt; font-size: 14pt;">Defendants.</div>
          </td>
          <td style="width: 1.51%; vertical-align: top;">
            <div style="line-height: 15.95pt; font-size: 14pt;">)</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">)</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">)</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">)</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">)</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">)</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">)</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">)</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">)</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">)</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">)</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">)</div>
            <div style="line-height: 15.95pt; font-size: 14pt;"> )</div>
            <div style="line-height: 15.95pt; font-size: 14pt;"> )<br>
            </div>
            <div style="line-height: 15.95pt; font-size: 14pt;">)</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">)</div>
          </td>
          <td style="width: 49.27%; vertical-align: middle;">
            <div style="margin-left: 7.2pt; line-height: 15.95pt; font-size: 14pt;">C.A. No. 2022-_______</div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; line-height: 15.95pt; margin-top: 12pt; margin-bottom: 12pt; font-size: 14pt; font-weight: bold;"><u>VERIFIED COMPLAINT</u></div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt; font-size: 14pt;">Plaintiffs Politan Capital Management LP and Politan Capital NY LLC (&#8220;<u>Plaintiffs</u>&#8221; or &#8220;<u>Politan</u>&#8221;), by and through their undersigned counsel, bring
      this Verified Complaint against Defendants Joe E. Kiani, H. Michael Cohen, Adam P. Mikkelson, Craig B. Reynolds, Julie A. Shimer Ph.D. (collectively, the &#8220;<u>Director Defendants</u>&#8221;) and Masimo Corporation (&#8220;<u>Masimo</u>&#8221; or the &#8220;<u>Company</u>&#8221;
      and, together with the Director Defendants, &#8220;<u>Defendants</u>&#8221;).</div>
    <div style="text-align: center; line-height: 15.95pt; margin-bottom: 12pt; font-size: 14pt; font-weight: bold;"><u>NATURE OF THE ACTION</u></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt; font-family: Arial,Helvetica,sans-serif;">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt; font-family: Arial,Helvetica,sans-serif;">This action
        challenges the validity of Masimo&#8217;s newly amended advance notice bylaws (the &#8220;<u>Bylaw Amendments</u>&#8221;) and the refusal by Masimo&#8217;s</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">Board of Directors (the &#8220;<u>Board</u>&#8221;) to disable onerous change of control provisions that Masimo adopted to entrench its incumbent directors in office.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">During the summer of 2022, Politan, an investment fund with a focus on driving long-term positive
        change through constructive engagement, acquired an 8.8% ownership stake in Masimo and requested a meeting with Masimo&#8217;s Chairman and Chief Executive Officer (&#8220;<u>CEO</u>&#8221;) Joe Kiani.&#160; At a private meeting between Mr. Kiani and Quentin Koffey,
        Politan&#8217;s founder, in early September 2022, Mr. Koffey expressed Politan&#8217;s interest in obtaining representation on Masimo&#8217;s Board.&#160; Just one week later, in an effort to prevent that from happening, the Board brazenly adopted the Bylaw Amendments,
        which are perhaps the most preclusive advance notice bylaws in Delaware history.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup>&#160; Indeed, Masimo has <font style="font-style: italic;">admitted</font> that it did so based on its &#8220;concerns that Politan might attempt to present matters
        for stockholder consideration at Masimo&#8217;s next annual meeting &#8230; .&#8221;</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Bylaw Amendments are inequitable and invalid and cannot stand.&#160; Among other things, they
        purport to require nominating stockholders to provide highly confidential and proprietary information, including the identity of</font></div>
    <br>
    <br>
    <hr noshade="noshade" align="left" style="background-color: #000000; border: 0px; height: 1px; width: 2in; margin-left: 0pt; margin-right: auto; color: #000000;">
    <div style="text-align: justify; line-height: 15.95pt; margin-bottom: 12pt; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup>&#160; A redline comparing the newly enacted Third Amended and Restated Bylaws (the &#8220;<u>Bylaws</u>&#8221;), which incorporate the Bylaw Amendments, with
      Masimo&#8217;s Second Amended and Restated Bylaws (the &#8220;<u>Prior Bylaws</u>&#8221;) is attached hereto as Exhibit A.&#160; Copies of the Bylaws and the Prior Bylaws are attached hereto as Exhibits B and C, respectively.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">2</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">certain investors, that they likely would be unwilling, unable and contractually prohibited from disclosing.&#160; As such, they preemptively block any investment fund stockholder from
      nominating candidates for election to the Board, thereby impeding the stockholder franchise and entrenching the incumbent Board in office.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">4.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Masimo&#8217;s Bylaw Amendments are so draconian that, as The Deal recently reported, activists and
        activist defense attorneys alike have expressed the view that they &#8220;represent an existential threat for activist campaigns.&#8221;&#160; Tellingly, an &#8220;unaffiliated activist defense adviser told The Deal he looked at the idea [of a provision requiring
        insurgent funds to identify underlying investors] previously but decided against implementing it over concerns about a Delaware court striking it down and worries about drawing &#8216;scathing reprimands&#8217; from proxy advisers in a subsequent proxy
        contest.&#8221;</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Bylaw Amendments are only the latest in Masimo&#8217;s long history of corporate governance
        failures which rank it among the worst, if the not the worst, of the companies making up the Russell 3000 Index (&#8220;<u>Russell 3000</u>&#8221;), a benchmark index of the entire U.S. stock market which represents approximately 96% of the American public
        equity market, as demonstrated by the following:</font></div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z7b33b15f20984a7f8d6edc836b38d382" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 99.35pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 72pt; line-height: 15.95pt; font-size: 14pt;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;"><font style="font-weight: bold;">Say-on-Pay</font>: Since 2011, when Masimo was first required to include Say on Pay in its proxy, <font style="font-weight: bold;">Masimo









                  has failed the vote six times</font>.&#160; Only two other companies in the entire Russell 3000 have as bad a record.&#160; Even in those years when Masimo did not fail its</div>
            </td>
          </tr>

      </table>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">3</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; margin-left: 99.35pt; line-height: 15.95pt; margin-bottom: 12pt; font-size: 14pt;">vote, its vote results still ranked in the bottom 14<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> percentile of all companies in the Russell 3000.</div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zdccbe29d61704479b9032819139c0cca" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 99.35pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 72pt; line-height: 15.95pt; font-size: 14pt;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;"><font style="font-weight: bold;">Director Withholds</font>:&#160; At Masimo&#8217;s 2022 Annual Meeting, its directors ranked in the <font style="font-weight: bold;">bottom 3</font><sup style="font-family: 'Times New Roman Bold', serif; font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup><font style="font-weight: bold;"> and 6</font><sup style="font-family: 'Times New Roman Bold', serif; font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup><font style="font-weight: bold;"> percentiles</font> of the entire Russell 3000.&#160; During the past ten years, Masimo directors have been, on average, in the bottom 21<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> percentile and only two times in the past decade has even a single Masimo independent
                director done better than the bottom 33<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup> percentile.&#160; Additionally, Mr. Kiani, the Chairman of the Board, has, on average during the last decade, been in the bottom 25<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> percentile.</div>
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;"> <br>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zb2bd816679ee4f15a94f7d7b9c7cdbce" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 99.35pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 72pt; line-height: 15.95pt; font-size: 14pt;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;"><font style="font-weight: bold;">Board Composition</font>:&#160; Masimo has a <font style="font-weight: bold;">staggered Board</font>, with the same individual serving as
                CEO and Chairman of the Board&#160; (&#8220;<u>Chairman</u>&#8221;), with <font style="font-weight: bold;">no Lead Independent Director</font> (&#8220;<u>LID</u>&#8221;)&#8212;94% of Russell 3000 companies have a LID or independent chair and 97% of Russell 3000 companies
                have either a non-staggered board or LID/independent chair.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">6.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Masimo&#8217;s director withhold rates and Say-on-Pay failures are stunning not only for the degree of
        stockholder frustration they evidence, but also for their duration&#8212;continuing year after year without any appropriate response by the Board.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">7.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">To make matters worse, the Board agreed to an acceleration provision in the employment agreement
        of Chairman and CEO Joe Kiani that would allow Mr. Kiani to receive hundreds of millions of dollars in severance payments (including a stock grant equal to approximately 5% of the Company) if only <font style="font-weight: bold; font-style: italic;">two</font> of Masimo&#8217;s five Board members are voted out of office.&#160; That acceleration provision impedes the stockholder franchise by coercing Masimo&#8217;s stockholders into opposing any change to the composition of the Board.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">4</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">8.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Against this backdrop of unchecked governance failures, Masimo&#8217;s stock price collapsed when
        stockholders learned of Masimo&#8217;s acquisition of Sound United LLC (&#8220;<u>Sound United</u>&#8221;).&#160; On February 15, 2022, Masimo (a nearly $14 billion market cap company at the time) announced the acquisition for $1.025 billion of Sound United, a consumer
        audio company that primarily sells speakers.&#160; The acquisition marked a detour from Masimo&#8217;s medical device business of selling pulse oximeters and accompanying sensors to hospitals (which constituted in excess of 90% of Masimo&#8217;s revenues at the
        time).&#160; Mr. Kiani stated the rationale for the deal was to gain distribution into Best Buy and Euronics for Masimo&#8217;s new smartwatch that would compete directly with Apple.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">9.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The market responded to that deal by erasing <font style="font-weight: bold; font-style: italic;">five times</font> the acquisition price&#8212;approximately <font style="font-weight: bold; font-style: italic;">$5.1 billion</font>&#8212;from Masimo&#8217;s market capitalization the day after the acquisition was announced, which amounted to
        approximately 70% of Masimo&#8217;s current market capitalization.&#160; As far as Politan is aware, based on extensive research, never before in the history of United States publicly traded companies has an acquiring company&#8217;s market cap declined by more
        than twice, let alone five times, the purchase price of a material acquisition (<font style="font-style: italic;">i.e.</font>, an acquisition that represents 5% or more of the acquiring company&#8217;s market cap).</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">10.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The stunning decrease in value reflects much more than mere market skepticism of the
        acquisition.&#160; A decrease of more than five times the</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">5</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">purchase price demonstrates that the market fears that a complete breakdown in accountability and oversight by Masimo&#8217;s Board will lead to a destruction of value far in excess of
      the purchase price.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">11.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Over the years, Delaware courts consistently have emphasized the critical importance of ensuring
        that stockholders have a say in the management of the companies they own through the free and fair exercise of the stockholder franchise.&#160; Indeed, as the Delaware Supreme Court has explained, the stockholder franchise &#8220;has been characterized as the
        &#8216;ideological underpinning&#8217; upon which the legitimacy of the directors&#8217; managerial power rests.&#8221;&#160; <font style="font-style: italic;">MM Cos. v. Liquid Audio, Inc.</font>, 813 A.2d 1118, 1126 (Del. 2003).&#160; A stockholder&#8217;s fundamental right to
        participate in the voting process includes the right to nominate individuals for election to a company&#8217;s board of directors.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">12.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Masimo&#8217;s Board has all but abrogated that right by adopting amendments to its advance notice
        bylaws that effectively preclude any investment fund stockholder, such as Politan, from nominating candidates for election to the Board.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">13.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">While all of the Bylaw Amendments identified herein are improper and should be invalidated, two
        of them stand out as particularly egregious.&#160; <font style="font-style: italic;">First</font>, by amending the definition of &#8220;Covered Person&#8221; in the Bylaws, the Bylaw Amendments require nominating stockholders that are investment funds to disclose</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">6</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">highly confidential information concerning the identities and investment holdings of their own limited partners as well as any <font style="font-style: italic;">family members</font>
      of those limited partners.&#160; As explained herein, that provision improperly conditions an investment fund stockholder&#8217;s right to nominate candidates for election to the Board on the disclosure of information concerning its <font style="font-style: italic;">passive</font> limited partners that the stockholder is unlikely to have, has no right to obtain, and otherwise is obligated to keep confidential.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">14.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">This expanded disclosure requirement serves no legitimate purpose.&#160; Indeed, while the Bylaw
        Amendments mandate that a nominating stockholder disclose this information to Masimo, the Questionnaire for Director Nominees (the &#8220;<u>D&amp;O Questionnaire</u>&#8221;) does not require any such expanded disclosure.&#160; Thus, incumbent Board members are not
        subject to the same disclosure requirement as are stockholder nominees.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">15.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">This discrepancy is particularly notable given that one of the Director Defendants, Adam
        Mikkelson, manages an investment fund that, earlier <font style="font-style: italic;">this year</font>, held a substantial investment in Masimo&#8217;s primary competitor (and <font style="font-style: italic;">no </font>investment in Masimo).<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup>&#160;
        That investment was not disclosed in Masimo&#8217;s public filings, including its proxy statement, which underscores that the Board does not</font></div>
    <br>
    <br>
    <hr noshade="noshade" align="left" style="background-color: #000000; border: 0px; height: 1px; width: 2in; margin-left: 0pt; margin-right: auto; color: #000000;">
    <div style="text-align: justify; line-height: 15.95pt; margin-bottom: 12pt; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup>&#160; <font style="font-style: italic;">See</font> Camber Capital Management, LLC, Institutional Investment Manager Holdings Report, Information
      Table (Form 13F-HR) (May 16, 2022).</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">7</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">believe such information is relevant or material to Masimo&#8217;s stockholders.&#160; Rather, it is intended to discourage investment fund stockholders from nominating candidates for
      election to the Board.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt; font-style: italic;">16.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;"><font style="font-style: italic;">Second</font>, the Bylaw Amendments
        require nominating stockholders to disclose (i) <font style="font-style: italic;">future</font> plans to nominate directors at <font style="font-style: italic;">other </font>public companies in the next 12 months and (ii) past proposals or
        nominations at <font style="font-style: italic;">other </font>public companies within the last 36 months, <font style="font-style: italic;">whether or not those proposals or nominations were ever publicly disclosed</font>.&#160; As with the expanded
        &#8220;Covered Person&#8221; disclosures, this serves no legitimate purpose beyond forcing investment fund stockholders to either disclose information that is highly confidential and proprietary or forfeit their right to nominate.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">17.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">To make matters worse, on the same day the Board adopted the Bylaw Amendments, it also adopted a
        shareholder rights agreement (a &#8220;poison pill&#8221;).&#160; In so doing, the Board chilled stockholder communication and effectively cut off both of the traditional means of holding a board accountable:&#160; the poison pill prevents stockholders from pursuing
        tender offers to change control of the Company, and the Bylaw Amendments make it impossible as a practical matter for a stockholder to launch a proxy contest, replace the Board, and redeem the pill.&#160; Thus, the Board&#8217;s adoption of the poison pill
        along with the Bylaw Amendments was unreasonably preclusive.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">8</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">18.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">If the unprecedented Bylaw Amendments are allowed to stand, the adverse effects on the
        stockholder franchise will be felt far beyond Masimo.&#160; Scores of other companies can be expected to rush to adopt similar, or identical, advance notice bylaws, imposing a significant drag on the stockholder franchise as many activist and other
        investment fund stockholders will be precluded or deterred from nominating candidates for election to the boards at those companies.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">19.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">A substantial decrease in activist campaigns would do significant harm to the stockholder
        franchise, given the critical role that activist and other investment fund stockholders play in pushing for change at underperforming companies and holding boards accountable.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">20.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Accordingly, Plaintiffs request that the Court:&#160; (i) declare that the Bylaw Amendments are
        unenforceable; (ii) find that the Director Defendants breached their fiduciary duties by approving and implementing the Bylaw Amendments; (iii) invalidate the Director Change of Control Provision (as defined below); and (iv) enjoin Masimo and the
        Board from taking any actions to prevent Politan from exercising its rights to nominate candidates for election to the Board in accordance with the Prior Bylaws.</font></div>
    <div style="margin-top: 6pt; margin-bottom: 12pt; line-height: 15.95pt; font-size: 14pt; font-weight: bold; text-align: center;"><u>JURISDICTION AND VENUE</u></div>
    <div style="text-indent: 72pt;"><font style="font-size: 14pt;">21.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">This Court has jurisdiction over this action pursuant to 8&#160;Del.&#160;C.&#160;&#167; 111 and 10 Del. C. &#167; 341.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">9</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">22.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">As directors of a Delaware corporation, the Director Defendants have consented to the
        jurisdiction of this Court pursuant to 10 Del.&#160;C. &#167; 3114.</font></div>
    <div style="text-align: center; line-height: 15.95pt; margin-bottom: 12pt; font-size: 14pt;"><font style="font-weight: bold;"><u>THE </u><u>PARTIES</u></font></div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt; font-weight: bold;">Politan Capital Management</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">23.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Plaintiff Politan Capital Management LP is a Delaware limited partnership and an investment
        advisor to the funds it manages.&#160; Politan, together with certain affiliates, beneficially owns 4,648,869 shares of Masimo common stock, representing approximately 8.8% of Masimo&#8217;s outstanding common shares.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">3</sup>&#160; Politan does not use any
        financial leverage and therefore owns its Masimo stock outright with no encumbrances.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">24.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Plaintiff Politan Capital NY LLC is a New York limited liability company and the record owner of
        1,000 shares of Masimo common stock.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">25.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Politan was founded in 2021 by Quentin Koffey, a &#8220;veteran activist&#8221; who has a reputation for
        &#8220;creating significant value for shareholders&#8221; by engaging in constructive private dialogue and, when necessary, nominating candidates for election to a company&#8217;s board:&#160; &#8220;Politan&#8217;s style is to amicably and quietly work with management to achieve
        its objectives.&#160; They do not send angry</font></div>
    <br>
    <br>
    <hr noshade="noshade" align="left" style="background-color: #000000; border: 0px; height: 1px; width: 2in; margin-left: 0pt; margin-right: auto; color: #000000;">
    <div style="text-align: justify; line-height: 15.95pt; margin-bottom: 12pt; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">3</sup>&#160; Politan filed a Schedule 13D on August 16, 2022 disclosing that it beneficially owned 4,431,284 shares of Masimo common stock.&#160; It subsequently
      filed an Amended Schedule 13D on September 27, 2022 disclosing its current holdings.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">10</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">public letters, and they do not seek proxy fights.&#160; However, they will also not back down from a proxy fight if their hand is forced.&#8221;</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">26.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Mr. Koffey&#8217;s constructive approach has benefitted stockholders.&#160; According to CNBC, &#8220;Koffey has
        created significant value for shareholders at companies like Lowe&#8217;s and has orchestrated some very positive transformations at companies like EQT.&#8221;</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">27.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Once it has secured board representation, Politan does not push an agenda aimed at generating
        short-term gains.&#160; Rather, it considers management&#8217;s strategic initiatives and proposed projects with an open mind, supporting those that it believes will create value for stockholders over the long term and opposing those that are likely to
        generate poor (or no) returns.&#160; Politan can employ such an approach because it has long-term capital to invest&#8212;the majority of its investors are locked-up for three to four years.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">28.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Politan has relayed to Masimo, both in a meeting and in correspondence, that Politan is &#8220;focused
        on long-term value creation and open-minded to the strategic initiatives [Masimo] announced.&#8221;&#160; But Politan also made clear that it is focused on the appropriate functioning of a board of directors to provide oversight and accountability.&#160; This
        accountability is exactly what the market has shown it believes is lacking at Masimo&#8212;and exactly what the Board seeks to</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">11</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">entrench itself against by adopting the Bylaw Amendments and maintaining other preclusive barriers to the unencumbered exercise of the stockholder franchise.</div>
    <div style="text-align: justify; line-height: 27.35pt; font-size: 14pt; font-weight: bold;">Masimo Corporation</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">29.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Founded in 1989, Defendant Masimo Corporation is a Delaware corporation with its headquarters in
        Irvine, California.&#160; Masimo is a supplier of pulse-oximetry monitoring technologies to hospitals&#8212;accounting for more than 90% of its revenues prior to the acquisition of Sound United.</font></div>
    <div style="text-align: justify; line-height: 27.35pt; font-size: 14pt; font-weight: bold;">The Director Defendants</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">30.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Defendant Joe E. Kiani is Masimo&#8217;s Founder, CEO and Chairman.&#160; Mr. Kiani has served as a
        director of Masimo and as Masimo&#8217;s CEO and Chairman of the Board since the Company&#8217;s formation in 1989.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">31.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Defendant H. Michael Cohen has served as a director of Masimo since 2018.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">32.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Defendant Adam P. Mikkelson has served as a director of Masimo since 2016.&#160; Mr. Mikkelson is an
        investment manager at Camber Capital Management, LLC (&#8220;<u>Camber</u>&#8221;), a healthcare-focused investment fund.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">33.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Defendant Craig B. Reynolds has served as a director of Masimo since 2014.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">34.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Defendant Julie A. Shimer, Ph.D. has served as a director of Masimo since 2019.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">12</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: center; line-height: 15.95pt; margin-bottom: 12pt; font-size: 14pt; font-weight: bold;"><u>FACTUAL BACKGROUND</u></div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z864a64bad8e14aa9bf07ba104e7e8f11" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; line-height: 15.95pt; font-size: 14pt; font-weight: bold;">A.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt; font-weight: bold;">Masimo Has Underperformed Despite Its Dominant Core Business</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">35.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Since its founding in 1989, Masimo has carved out a dominant position in a niche industry.&#160;
        Masimo produces and supplies monitoring technologies and automation solutions to hospitals and other healthcare organizations.&#160; Masimo&#8217;s core business, which accounted for more than 90% of Masimo&#8217;s sales prior to the Sound United acquisition, is
        pulse oximeter devices and accompanying sensors for patient monitoring.&#160; Masimo&#8217;s pulse oximetry devices are best-in-class; they have been shown to perform better and reduce adverse events, length of hospital stays, and medical costs.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">36.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The combination of its best-in-class pulse oximetry products and the general structure of the
        pulse oximetry industry, which has high barriers to entry and is not tied to economic cycles, provides Masimo with a stable revenue base from its core business.&#160; Indeed, because the technology used in pulse oximetry is highly specialized and
        critical to patient health, companies hoping to break into the market would need to demonstrate the safety and soundness of their devices through years of approved medical studies before they could effectively compete with Masimo.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">37.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Masimo also generates recurring revenue by employing a &#8220;razor-razorblade&#8221; style business model,
        whereby Masimo sells hospitals both measuring devices and the disposable replacement sensors used with the devices.&#160; Masimo and</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">13</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">customers generally enter into five-year contracts, resulting in 80% annual recurring revenue.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">38.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The strength of Masimo&#8217;s pulse oximetry technology, together with the high costs for hospitals
        considering switching to an alternative provider, drive a contract renewal rate of greater than 98%.&#160;&#160; </font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">39.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Masimo&#8217;s pulse oximetry business has performed well this year, with EBITDA generation
        year-to-date in-line with the Company&#8217;s guidance, excluding foreign exchange impact.&#160; This performance is notable given the difficult business environment, which has led the majority of Masimo&#8217;s medical device peers to reduce their expectations for
        earnings during the year.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">40.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Notwithstanding the strength of its pulse oximetry business, Masimo&#8217;s total stockholder return
        has significantly underperformed both its peers and the S&amp;P 500 on a trailing one-,&#160;three-, and five-year basis, which is the standard time frames and metric used by Institutional Shareholder Services Inc. (&#8220;<u>ISS</u>&#8221;), a leading proxy
        advisory firm, to evaluate a company&#8217;s (and therefore its board&#8217;s) performance.&#160; The following chart reflects Masimo&#8217;s historical stock price</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">14</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">performance as of the date of Politan&#8217;s Schedule 13D filing on August 16, 2022 compared to its peer companies and relevant indices.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">4</sup></div>
    <br>
    <div style="text-align: center; line-height: 31.9pt;">
      <div><img src="image00003.jpg"></div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z9445ff49cb9248d792053ab880c05622" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; line-height: 15.95pt; font-size: 14pt; font-weight: bold;"> <br>
              </div>
              <div style="text-align: left; line-height: 15.95pt; font-size: 14pt; font-weight: bold;">B.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt; font-weight: bold;"> <br>
              </div>
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt; font-weight: bold;">Masimo&#8217;s History of Poor Corporate Governance</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;"> 41.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Masimo&#8217;s stock price underperformance is attributable, in large part, to stockholders&#8217; growing
        dissatisfaction with Masimo&#8217;s long history of corporate governance failures and increasing fears that the Board had abdicated its responsibility to conduct oversight of the Company and its management, which culminated in the market&#8217;s stunningly
        negative reaction to the Sound United acquisition (discussed in further detail below).</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">42.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">For instance, a significant contingent of Masimo&#8217;s stockholders have refused to support the
        re-election of incumbent Board members, even when those Board members were unopposed.&#160; At Masimo&#8217;s 2022 Annual Meeting, the two</font></div>
    <br>
    <br>
    <hr noshade="noshade" align="left" style="background-color: #000000; border: 0px; height: 1px; width: 2in; margin-left: 0pt; margin-right: auto; color: #000000;">
    <div style="text-align: justify; line-height: 15.95pt; margin-bottom: 12pt; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">4</sup>&#160; Peer companies are those selected by Masimo in its proxy statement for this year&#8217;s annual meeting, as well as those selected as peers by
      Bloomberg.&#160; &#8220;Proxy Peers with Same Growth Profile&#8221; are those proxy peers with a three-year forward revenue compound annual growth rate (CAGR) greater than 10%.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">15</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">Board members up for re-election ranked in the bottom 3% and 6% of the entire Russell 3000 in terms of withhold votes.&#160; Over the past ten years, Masimo directors, on average, were
      in the bottom 21<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> percentile in terms of withhold votes.&#160; Only twice in the past decade has even a single Masimo independent director done better than the bottom 33<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup> percentile.&#160; Mr. Kiani has, on average, been in the bottom
      25<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> percentile during the last decade.</div>
    <div style="text-align: justify; margin-left: 72pt; line-height: 27.35pt; font-size: 14pt; font-style: italic;">Masimo&#8217;s Poor Governance Structure</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">43.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">At the most basic level, the structure of Masimo&#8217;s Board is problematic.&#160; Masimo has a staggered
        Board, lacks a lead independent director, and does not separate the Chairman and CEO positions.&#160; Indeed, despite Masimo touting its &#8220;corporate governance guidelines,&#8221; which are ostensibly intended to ensure that the Board can &#8220;make decisions that
        are independent of our management,&#8221; one of the guidelines is that &#8220;except in unusual circumstances, the positions of Chairman of our Board and CEO will be held by the same person.&#8221;<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">5</sup>&#160; By contrast, 94% of Russell 3000 companies have a lead
        independent director or independent chairperson.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">44.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">One of a board&#8217;s most fundamental and critically important functions is to select a company&#8217;s
        CEO, monitor that individual&#8217;s performance, and hold them accountable for underperformance or poor strategic decision-making.&#160; To</font></div>
    <br>
    <br>
    <hr noshade="noshade" align="left" style="background-color: #000000; border: 0px; height: 1px; width: 2in; margin-left: 0pt; margin-right: auto; color: #000000;">
    <div style="text-align: justify; line-height: 15.95pt; margin-bottom: 12pt; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">5</sup>&#160; Masimo, Proxy Statement (Form 14A) (Apr. 4, 2022), at 26.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">16</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">be clear, Politan is not advocating through this action for Mr. Kiani&#8217;s removal as Masimo&#8217;s CEO, but regardless, as a matter of corporate governance, it would be exceedingly
      difficult for the Board to remove him from office.&#160; Under Mr. Kiani&#8217;s employment agreement, even a termination of his employment for cause must be approved by at least 75% of the Board, meaning that all four other Board members would need to
      unanimously support his removal.</div>
    <div style="text-align: justify; margin-left: 72pt; line-height: 27.35pt; font-size: 14pt; font-style: italic;">Masimo&#8217;s Excessive Executive Compensation and Perks</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">45.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Since 2011, Masimo has been required to hold advisory, non-binding votes at its annual meetings
        to approve the compensation of its named executive officers, which are commonly known as &#8220;Say-on-Pay&#8221; votes.&#160; In <font style="font-weight: bold; font-style: italic;">six of the last twelve years</font>, Masimo failed this vote with as many as <font style="font-weight: bold; font-style: italic;">70%</font> of shares voting against in some years.&#160; Only two other companies in the entire Russell 3000 have a record that poor.&#160; Even in the years in which Masimo did not outright fail its
        Say-on-Pay vote, Masimo still ranked in the bottom 14<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> percentile of the entire Russell 3000.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">46.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Part of the reason Masimo&#8217;s stockholders have expressed such strong disapproval of its executive
        compensation is the sheer excess of the compensation Masimo pays to its executives like Mr. Kiani.&#160; For example, in 2020 and 2021 Mr. Kiani&#8217;s total compensation was approximately <font style="font-weight: bold; font-style: italic;">three to nearly
          four times </font>median Russell 3000 CEO compensation, as calculated by ISS.&#160; Mr. Kiani&#8217;s</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">17</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">total compensation as a percentage of Masimo&#8217;s sales was approximately <font style="font-weight: bold; font-style: italic;">four times </font>the median for Russell 3000
      companies during that same time period.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">47.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Over the years, the Board also has approved excessive perks for Mr. Kiani, including nearly a
        million dollars for private security services for Mr. Kiani and his family at his personal residence or other non-Masimo facilities that were unrelated to Masimo&#8217;s business.&#160; Those payments drew scrutiny by ISS, which noted: &#8220;The company provided a
        large security-related perquisite to CEO Kiani.&#160; The amount of compensation related to this perquisite, which in 2021 was provided by only 2 percent of companies in the Russell 3000 Index, significantly exceeded the index median.&#8221;</font></div>
    <div style="text-align: justify; margin-left: 72pt; line-height: 27.35pt; font-size: 14pt; font-style: italic;">Masimo&#8217;s Improper Payments That Benefit Mr. Kiani Personally</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">48.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">In addition, the Company pays millions of dollars to other entities associated with Mr. Kiani,
        but those payments serve no legitimate corporate purpose.&#160; For example, Masimo makes cash contributions to the Masimo Foundation for Ethics, Innovation and Competition in Healthcare (the &#8220;<u>Masimo Foundation</u>&#8221;), a non-profit organization for
        which Mr. Kiani is the Chairman, his wife is a director, and his sister was formerly a director (for at least five years).&#160; Masimo has contributed over $30 million to the Masimo Foundation since its inception in 2010.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">49.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Masimo Foundation&#8217;s admirable mission is &#8220;to encourage and promote activities, programs, and
        research opportunities that improve patient</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">18</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">safety and deliver advanced healthcare to people worldwide who may not otherwise have access to lifesaving technologies.&#8221;&#160; Yet despite its mission to focus on patient safety and
      healthcare, the Masimo Foundation regularly uses a substantial portion of the funds it receives from Masimo to make contributions to politicians and their foundations at the direction of Mr. Kiani and his family members, which, upon information and
      belief, provides personal benefits to Mr. Kiani to present himself as a benefactor for causes he personally believes in but are unrelated to Masimo.&#160; For instance, in its last four annual public tax returns, the Masimo Foundation reported making
      nearly $6.4 million in contributions to organizations associated with Presidents Carter, Clinton, Obama, and Biden for &#8220;general support&#8221;&#8212;approximately 50% of the grants and contributions the Masimo Foundation made during that period.&#160; The Masimo
      Foundation has donated nearly $8.5 million to those organizations since its founding.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">50.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Masimo also makes payments to Cercacor Laboratories, Inc. (&#8220;<u>Cercacor</u>&#8221;), an independent
        entity spun off from Masimo in 1998.&#160; Mr. Kiani is the Chairman and CEO of Cercacor and receives a salary and equity compensation in connection with those roles.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">51.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Pursuant to a cross-licensing agreement between Masimo and Cercacor related to certain
        intellectual property (the &#8220;<u>CLA</u>&#8221; (Exhibit D)), Masimo is obligated to make minimum royalty payments of $5 million per year to Cercacor.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">19</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">Masimo&#8217;s aggregate royalty payment liabilities to Cercacor were approximately $13.5 million, $13.3 million, and $12.1 million, for the years ended January 1, 2022, January 2, 2021
      and December 28, 2019, respectively.&#160; In addition, as discussed below, Masimo must make additional minimum royalty payments to Cercacor under the CLA in the event Mr. Kiani ceases to be Masimo&#8217;s CEO.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">52.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Similarly, Masimo makes payments to a company founded by Mr. Kiani called Like Minded Media
        Ventures (&#8220;<u>LMMV</u>&#8221;), at which Mr. Kiani continues to serve as a director.&#160; Masimo describes LMMV in SEC filings as a &#8220;team of storytellers that create content focused in the areas of true stories, social causes and science.&#8221;&#160; Masimo pays LMMV
        and certain of its subsidiaries hundreds of thousands of dollars for &#8220;audiovisual production services promoting brand awareness,&#8221; software development, and certain patents.</font></div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z31c6358f61e24d39a2de20de173f5ae3" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; line-height: 15.95pt; font-size: 14pt; font-weight: bold;">C.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt; font-weight: bold;">The Board Agrees to Coercive Acceleration Provisions in Mr. Kiani&#8217;s Employment Agreement and the CLA</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">53.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">In yet another example of the Board&#8217;s efforts to shield itself from accountability for Masimo&#8217;s
        poor corporate governance, the Board embedded acceleration provisions in Mr. Kiani&#8217;s Amended and Restated Employment Agreement (as amended, the &#8220;<u>Employment Agreement</u>&#8221; (Exhibit E)) that are triggered if there is a &#8220;Change of Control,&#8221; which
        is defined in the Employment Agreement to include, among other things, a change in the composition of more than</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">20</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">one third of the Board during a rolling 24-month period, <font style="font-style: italic;">i.e.</font>, if only two of Masimo&#8217;s five Board members are voted out of office (the &#8220;<u>Director









        Change of Control Provision</u>&#8221;).&#160; (Employment Agreement &#167; 9(iii).)</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">54.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Specifically, Section 9(iii) of the Employment Agreement states, in relevant part, that a Change
        of Control takes place if:</font></div>
    <div style="text-align: justify; margin-right: 36pt; margin-left: 72pt; line-height: 15.95pt; margin-bottom: 12pt; font-size: 14pt;">
      <div style="line-height: 15.95pt; font-family: Arial,Helvetica,sans-serif;">there shall occur a change in the Board in which the individuals who constituted the Board at the beginning of the twenty-four (24) month period immediately preceding such
        change <font style="font-style: italic;">cease for any reason to constitute two-thirds or more of the directors then in office.</font> For purposes of this Section 9(iii), a director (other than a director whose initial assumption of office is in
        connection with an actual or threatened election contest, including but not limited to, a consent solicitation, relating to the election of directors of the Company) whose election by the Board or whose nomination for election by the stockholders
        of the Company was approved by a vote of at least a majority of the directors then in office either who were directors at the beginning of such period or whose election or nomination for election was previously so approved will be treated as a
        member of the Board at the beginning of the twenty-four (24) month period.</div>
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">55.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Thus, under the terms of the Employment Agreement, a Change of Control triggered by reason of
        the Director Change of Control Provision constitutes &#8220;Good Reason&#8221; for Mr. Kiani to terminate his employment&#8212;<font style="font-style: italic;">i.e.</font>, it gives rise to entitlements on an essentially &#8220;single-trigger&#8221; basis even if there is no
        change in Mr. Kiani&#8217;s pay or authority, simply because the Company&#8217;s stockholders determined to elect directors different than those pre-approved by the Board.&#160; (<font style="font-style: italic;">Id.</font> &#167;&#160;7.4.)&#160; Upon a termination for Good
        Reason, Masimo is obligated under the</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">21</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">Employment Agreement to: (i) pay Mr. Kiani a severance benefit equal to two times his base salary and average annual bonus; (ii) vest all of Mr. Kiani&#8217;s stock options and other
      equity awards; (iii) issue shares to Mr. Kiani in respect of 2.7 million restricted share units (&#8220;<u>RSUs</u>&#8221;) (equivalent to a stunning 5% of the Company); and (iv) make a single lump-sum cash payment of $35 million to Mr. Kiani (collectively, the
      &#8220;<u>Good Reason Termination Payments</u>&#8221;).&#160; (<font style="font-style: italic;">Id.</font> &#167; 8.4.)</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">56.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Notably, even if Mr. Kiani <font style="font-weight: bold; font-style: italic;">does not</font>
        terminate his employment after a Change of Control, he is still entitled to receive his stock options and equity awards, the 2.7 million RSUs (5% of the Company) and the $35 million cash payment, all of which vest in equal installments over a
        two-year period (the &#8220;<u>Continuous Service Payments</u>&#8221;).&#160; (<font style="font-style: italic;">Id.</font> &#167; 8.4(iii)(3).)</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">57.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The payments Masimo must make to Mr. Kiani after a Change of Control are astronomical.&#160; For
        instance, if a Change of Control had occurred on December 31, 2021, Mr. Kiani would have been entitled to Good Reason Termination Payments worth nearly<font style="font-weight: bold; font-style: italic;"> $913 million</font><font style="font-weight: bold;">&#160;</font>or Continuous Service Payments worth more than <font style="font-weight: bold; font-style: italic;">$825 million</font>.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">58.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Director Change of Control Provision serves no legitimate corporate purpose.&#160; Rather, it is
        intended to coerce stockholders into supporting the incumbent Board in a contested election in order to avoid triggering the Director</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">22</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">Change of Control Provision and requiring Masimo to pay out hundreds of millions of dollars.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">59.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Likewise, the CLA includes change of control provisions that are triggered if Mr. Kiani ceases
        to be the CEO of Masimo or if non-affiliates directly or indirectly gain 50% or more of Masimo&#8217;s voting shares.&#160; (CLA &#167; 1.4.)</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">60.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Upon such a change in control of Masimo, Masimo is obligated to, among other things, pay
        Cercacor substantially increased aggregate minimum royalties and also specified minimum royalty fees per product.&#160; (<font style="font-style: italic;">Id.</font> &#167;&#167; 5.4(g), 5.6.)&#160; Instead of the current $5 million minimum, Masimo would be obligated
        to pay an aggregate minimum royalty of <font style="font-weight: bold; font-style: italic;">$15-17 million per year</font>, amounts that are several million dollars more than what Masimo actually paid per year during the past three fiscal years.&#160;
        (<font style="font-style: italic;">See id.</font>)</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">61.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Like the change of control provision in Mr. Kiani&#8217;s Employment Agreement, the change of control
        provision in the CLA serves no legitimate corporate purpose and is solely intended to entrench Mr. Kiani in office.</font></div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z19d29f9012f84104863c98243b391b72" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; line-height: 15.95pt; font-size: 14pt; font-weight: bold;">D.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt; font-weight: bold;">The Market Has Demonstrated Its Loss of Confidence in the Board&#8217;s Stewardship of Masimo</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">62.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Long-simmering stockholder discontent with the Board&#8217;s inaction in the face of serious corporate
        governance failures finally boiled over when Masimo announced that it was acquiring Sound United&#8212;a consumer technology</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">23</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">company that sells speakers and headphones under brands such as Bowers &amp; Wilkins, Denon, and Polk Audio&#8212;for approximately $1.025 billion.&#160; The Sound United acquisition, which
      represented a departure by Masimo from its core pulse oximetry business into unrelated consumer audio products, was the final straw for many of Masimo&#8217;s stockholders.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">63.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">On February 15, 2022, the day on which Masimo announced the Sound United acquisition, the
        Company&#8217;s stock closed at $228 per share.&#160; The following day, the stock fell <font style="font-weight: bold; font-style: italic;">37%</font>, to $144 per share.&#160; Thus, the market responded to news of a $1.025 billion acquisition by erasing <font style="font-weight: bold; font-style: italic;">five times </font>that amount&#8212;approximately <font style="font-weight: bold; font-style: italic;">$5.1 billion</font>&#8212;from Masimo&#8217;s market cap.&#160; Masimo&#8217;s stock price remains around that same
        depressed level to this day.</font></div>
    <div style="text-indent: 72pt;"><font style="font-size: 14pt;"> <br>
      </font></div>
    <div style="text-align: center; line-height: 27.35pt; font-size: 14pt;">&#160;<img src="image00002.jpg"></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">24</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">64.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Such a drop in value is extremely rare, if not unprecedented.&#160; To Politan&#8217;s knowledge, based on
        extensive research, never before in the history of United States publicly traded companies has an acquiring company&#8217;s market cap declined by more<font style="font-style: italic;">&#160;</font>than <font style="font-weight: bold; font-style: italic;">two</font>
        times, let alone <font style="font-weight: bold; font-style: italic;">five</font> times, the purchase price of the acquisition where the acquisition was material (<font style="font-style: italic;">i.e.</font>, 5% or more of the acquiring company&#8217;s
        market cap).</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">65.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The market&#8217;s reaction to the Sound United acquisition is a clear signal that the market has lost
        confidence in the Board&#8217;s ability to exercise oversight over Masimo&#8217;s management.&#160; Indeed, a CNBC commentator reported that Masimo &#8220;has become a public company run like a private company&#8221; with &#8220;a founder/CEO making a great product and using the
        cash flow to fund pet projects.&#8221;&#160; That commentator further noted &#8220;now the milk is starting to spoil as [Mr.] Kiani pursues pet/science projects&#8221; such that &#8220;it has become obvious that the company needs a more objective board to oversee the
        discipline of R&amp;D spending.&#8221;</font></div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zb739962abfcd4f2b87785e0a20f0b212" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; line-height: 15.95pt; font-size: 14pt; font-weight: bold;">E.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt; font-weight: bold;">Politan Seeks to Engage With Masimo&#8217;s Board and Management on the Company&#8217;s Strategic Direction</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">66.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">During the summer of 2022, Politan concluded that Masimo presented an attractive buying
        opportunity because the price of its common stock significantly undervalued its core pulse oximetry business, in substantial part because the market had lost confidence in the Board&#8217;s stewardship.&#160; Politan had not,</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">25</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">and still has not, formed a firm opinion on the merits of Masimo&#8217;s smartwatch or other strategic initiatives, but Politan recognizes the clear substantial value in fixing the
      oversight and governance of the Company.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">67.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">On August 16, 2022, Politan filed a Schedule 13D with the SEC disclosing that it owned an 8.4%
        position in Masimo&#8217;s common stock.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">6</sup>&#160; Politan stated that it intended to engage in conversations, meetings and other communications with, among others, certain members of the Board and the management team.&#160; Politan further disclosed that
        it intended to discuss Masimo&#8217;s &#8220;business, operations, financial condition, strategic plans, governance, the composition of the executive suite and board and possibilities for changes thereto, as well as other matters related to [Masimo.]&#8221;&#160; Upon
        the filing of Politan&#8217;s Schedule 13D, Masimo&#8217;s stock price rose by 6%.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">68.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Immediately before, and again shortly after, filing the Schedule 13D, Mr. Koffey requested a
        meeting with Mr. Kiani to begin the process of constructive engagement.&#160; Initially, Masimo ignored that request and instead offered to set up a telephone call between Mr. Koffey and Masimo&#8217;s Chief Financial Officer and head of Investor Relations.</font></div>
    <br>
    <br>
    <hr noshade="noshade" align="left" style="background-color: #000000; border: 0px; height: 1px; width: 2in; margin-left: 0pt; margin-right: auto; color: #000000;">
    <div style="text-align: justify; line-height: 15.95pt; margin-bottom: 12pt; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">6</sup>&#160; Politan subsequently filed an Amended Schedule 13D on September 27, 2022, disclosing that it had increased its holdings to 8.8% of Masimo&#8217;s
      common stock.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">26</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">69.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">After repeated requests, Mr. Kiani finally agreed to a meeting with Mr. Koffey on September 2,
        2022.&#160; In that meeting, the parties discussed Masimo&#8217;s corporate governance, strategic initiatives, and financial performance.&#160; In addition, Mr. Koffey expressed his interest in obtaining representation on Masimo&#8217;s Board, and made clear that
        Politan was approaching the situation with an open mind, would reserve judgment on any of Masimo&#8217;s strategic initiatives, and had a strong focus on return on invested capital in order to be a good steward of stockholder resources.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">70.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">At the conclusion of the meeting, Mr. Koffey requested that Mr. Kiani arrange for a follow-up
        meeting with Masimo&#8217;s entire Board (consisting of the four other directors), which he reiterated by email on September 6, 2022.&#160; Mr. Kiani declined to do so.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">71.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Instead, Mr. Kiani replied on September 8, 2022 to inform Mr. Koffey that &#8220;members of our Board
        and management team are planning to meet this fall with many of our large shareholders to get their views and input.&#160; They would welcome meeting with you as well as part of that process.&#8221;</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">72.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Mr. Koffey followed up by email on September 16, 2022, asking Mr. Kiani to reconsider his
        apparent rejection of Politan&#8217;s request for a meeting with the whole Board.&#160; Mr. Koffey noted that while Politan encourages and is supportive of the Board&#8217;s general stockholder outreach efforts, Politan believes it is incumbent</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">27</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">upon the Board to promptly arrange a meeting between the Board and Masimo&#8217;s largest stockholders (including Politan) when the stockholder specifically requests such a meeting.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">73.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Mr. Kiani has yet to respond to Mr. Koffey&#8217;s September 16, 2022 email, nor has Masimo scheduled
        any meeting with Politan as part of its stockholder outreach efforts.</font></div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z8eb803f0bbad4c6788570a24caabd3b5" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; line-height: 15.95pt; font-size: 14pt; font-weight: bold;">F.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt; font-weight: bold;">Rather Than Engage With Politan, the Board Attempts to Entrench Itself by Amending Masimo&#8217;s Advance Notice Bylaws</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">74.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Instead of engaging with Politan in a constructive manner, the Board sought to entrench itself
        in office by making it all but impossible for Politan to nominate candidates for election to the Board.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">75.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">As is the case for many public companies, Masimo&#8217;s bylaws have long contained advance notice
        provisions, which require stockholders seeking to nominate candidates for Masimo&#8217;s Board to make voluminous disclosures concerning the stockholder and its nominee(s).&#160; However, on September 9, 2022&#8212;less than a month after Politan filed its Schedule
        13D and only <font style="font-weight: bold; font-style: italic;">five business days</font> after the meeting between Mr. Koffey and Mr. Kiani&#8212;the Board adopted and approved, effective immediately, certain amendments to the advance notice
        provisions in Masimo&#8217;s bylaws.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">28</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">76.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Notably, that same day, the Board also adopted a poison pill.&#160; By doing so, the Board
        effectively cut off both of the traditional means available to a stockholder to hold a board accountable: the poison pill prevents a tender offer to gain control of the Company, and the Bylaw Amendments make it impossible as a practical matter for
        the stockholder to launch a proxy contest, replace the Board, and redeem the pill.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">77.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The timing and content of the Board&#8217;s adoption of the Bylaw Amendments makes clear that they
        were adopted for the express purpose of preventing Politan, or any other investment fund stockholder, from nominating a dissident slate of directors for election to the Board.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">78.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Indeed, Masimo has admitted that the Bylaw Amendments were aimed squarely at Politan&#8212;in a letter
        dated October 19, 2022, Masimo stated that the Board adopted the Bylaw Amendments &#8220;to address well-founded concerns that Politan might attempt to present matters for stockholder consideration at Masimo&#8217;s next annual meeting without providing the
        accurate and complete information stockholders would need to cast an informed vote.&#8221;&#160; Masimo has never articulated its purported basis for any such &#8220;well-founded&#8221; concerns, as plainly there are none.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">79.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">In practice, the Bylaw Amendments impose such onerous requirements that, if allowed to stand,
        they would significantly chill stockholders&#8217; ability to nominate candidates for election to Masimo&#8217;s Board.&#160; Now, to exercise the</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">29</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">right to nominate candidates for the Board, the Bylaw Amendments require stockholders to disclose highly sensitive and confidential information while also creating burdensome
      obligations to collect vast quantities of information from far-flung sources, including information that the Board knows activist and other investment fund stockholders will not be able to obtain.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">80.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">In many instances, the Bylaw Amendments are so vague that they leave a nominating stockholder
        without any objective basis by which to evaluate whether it has complied with them.&#160; As a result, the Bylaw Amendments vest the Board with virtually unfettered discretion to accept or reject nominations for any reason or no reason at all.&#160; In sum,
        the new disclosures required by the Bylaw Amendments serve no purpose other than to entrench Masimo&#8217;s incumbent directors and impede the stockholder franchise.</font></div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zb6349cf59c694b89a201d8a7e81cc9f8" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 36pt; line-height: 15.95pt; font-size: 14pt; font-style: italic;">1.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt; font-style: italic;">The Bylaw Amendments Require the Nominating Stockholder to Disclose Proprietary, Confidential or Unobtainable Information Concerning Its Outside
                Investors</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">81.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Perhaps the most troubling aspect of the Bylaw Amendments arises from a modification to the term
        &#8220;Covered Person,&#8221; which has the effect of imposing new and unprecedented disclosure requirements on nominating stockholders that are investment funds.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">82.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Specifically, the term &#8220;Covered Person&#8221; includes, in addition to the nominating stockholder: (i)
        any person or entity holding a &#8220;5% or larger member,</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">30</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">limited partner or similar economic interest&#8221; in the nominating stockholder and (ii) &#8220;Related Persons,&#8221; which is vaguely defined to include persons who have acted in concert with
      the nominating stockholder within the last two years, whether or not regarding Masimo.&#160; (Bylaws Art. I, &#167; 1(9)(b).)</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">83.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">For each such Covered Person&#8212;<font style="font-style: italic;">i.e.</font>, for each limited
        partner&#8212;the Bylaw Amendments require the nominating stockholder to disclose both the name and address of the Covered Person and granular information about the Covered Person&#8217;s investment holdings, including &#8220;any significant equity or other interest
        held by the Covered Person in any principal competitor of the Company or any counterparty to any litigation in which the Company is involved,&#8221; (the &#8220;<u>Covered Persons Disclosures</u>&#8221;).&#160; (Bylaws Art. I, &#167;&#167;&#160;1(4)(a)(i)(C), (4)(c)(i)-(iii).)</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">84.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Accordingly, by their plain terms, the Covered Persons Disclosures require investment fund
        nominating stockholders to (i) disclose both the names and addresses of their own limited partners to Masimo, and (ii) determine whether any of those limited partners in turn hold investments in any key competitor to, or litigation adversary with,
        Masimo, and disclose any such responsive information to Masimo.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">85.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Thus, for example, if one of a nominating stockholder&#8217;s 5% or greater limited partners held an
        equity interest in Apple, a company with which Masimo is currently engaged in litigation, the nominating stockholder would need</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">31</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">to identify that limited partner and disclose information about the limited partner&#8217;s interest in Apple.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">86.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Covered Persons Disclosures are egregious for numerous reasons.&#160; <font style="font-style: italic;">First</font>, at the most basic level, the Covered Persons Disclosures contravene well-established norms of confidentiality in the investment fund industry by requiring investment fund stockholders to disclose the names of their limited
        partners to Masimo.&#160; The identities of an investment fund&#8217;s outside investors are among its most valuable trade secrets and proprietary information.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt; font-style: italic;">87.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;"><font style="font-style: italic;">Second</font>, many institutional
        investors that allocate capital to investment funds (including but not limited to activist funds) require that their names and investment allocations be kept confidential unless disclosure is required by law, rule, or regulation.&#160; In such a case,
        the nominating stockholder would be in a Catch-22&#8212;either it could comply with the Covered Persons Disclosures and breach its confidentiality obligations to its own limited partners, or it could abide by its obligations to its limited partners and
        have its nomination rejected.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">88.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Institutional investors&#8217; desire to keep their names and investment allocations confidential is
        eminently reasonable.&#160; For example, a sovereign wealth fund or pension fund may be reluctant to be publicly associated with efforts to influence strategy and corporate governance at United States public companies.&#160; That reticence is understandable,
        both from a public relations standpoint and, more</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">32</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">so, when considering that these are <font style="font-style: italic;">passive </font>investors with no influence on the activist fund&#8217;s strategy.&#160; Indeed, Politan&#8217;s limited
      partners have no discretionary authority whatsoever over Politan&#8217;s investments or investment strategy.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt; font-style: italic;">89.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;"><font style="font-style: italic;">Third</font>, because institutional
        investors do not want their names and allocations disclosed&#8212;even privately to Masimo&#8212;the Covered Persons Disclosures, which one would reasonably expect to be broadly adopted by public companies, will make it exponentially harder for investment
        funds to raise capital from such investors.&#160; The end result would be significantly less stockholder activism across all public companies.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt; font-style: italic;">90.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 14pt; font-family: Arial,Helvetica,sans-serif; font-style: italic;">Fourth</font><font style="font-size: 14pt;">, investment fund stockholders would reasonably be concerned about the manner in which Masimo would use information about their limited partners.&#160; Disclosing the identities of those limited partners could expose them to
        harassment or other pressure tactics by Masimo in an effort to inflict damage on the nominating stockholder&#8217;s business relationships.&#160;</font>
      <div style="text-align: left;">
        <div></div>
      </div>
      <font style="font-size: 14pt;"></font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt; font-style: italic;">91.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;"><font style="font-style: italic;">Fifth</font>, it would be impossible, as a
        practical matter, for an investment fund stockholder to comply with the Covered Persons Disclosures requirement.&#160; Investment funds generally do not have access to information concerning the other investments of their limited partners.&#160; As noted, in
        many cases those limited partners include entities like sovereign wealth funds or pension funds, which themselves manage vast amounts of money.&#160; Even if those entities were</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">33</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">willing to disclose their investment holdings, which is highly unlikely, the odds that the nominating stockholder would be able to collect such information in a timely manner are
      exceedingly low.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt; font-style: italic;">92.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;"><font style="font-style: italic;">Sixth,</font> not all litigation is
        discoverable, much less easily.&#160; Litigation may be filed internationally or in federal or state court in any of the 50 states.&#160; The dockets of many of those courts are not readily accessible.&#160; Moreover, to the extent &#8220;litigation&#8221; includes private
        arbitration, there may be no way to determine if an investor is a party to any such dispute.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">93.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 14pt;">The Board, advised by sophisticated activist defense counsel,<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">7</sup> is fully aware that
        there is no way an investment fund stockholder could comply with the Covered Persons Disclosures.&#160; Indeed, that is precisely the point.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">94.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Masimo has no legitimate need for the information required by the Covered Persons Disclosures.&#160;
        That information&#8212;which concerns the identities and investments of passive investors in an investment fund&#8212;has no bearing whatsoever on the fitness of a proposed candidate for election to the Board.</font></div>
    <br>
    <br>
    <hr noshade="noshade" align="left" style="background-color: #000000; border: 0px; height: 1px; width: 2in; margin-left: 0pt; margin-right: auto; color: #000000;">
    <div style="text-align: justify; line-height: 15.95pt; margin-bottom: 12pt; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">7</sup>&#160; There can be no doubt that Masimo adopted the Bylaw Amendments to improperly act as a surrogate poison pill aimed at stockholders who dare to
      run a proxy contest for even a minority of Board seats.&#160; <font style="font-style: italic;">See</font> &#8220;Proxy Tactics Are Changing:&#160; Can Advance Notice Bylaws Do What Poison Pills Cannot?&#8221;, John C. Coffee, Jr., 2022 WLNR 33331575 (October 19, 2022)
      (&#8220;in the takeover war, the poison pill is no longer the absolute showstopper it once was and can be outflanked by activist hedge funds seeking to run a proxy contest&#8212;even if only for a minority of the board. . . .&#8221;).</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">34</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">95.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Masimo claims that the Bylaw Amendments, and the Covered Persons Disclosures in particular, are
        necessary to &#8220;protect against undisclosed conflicts of interest adverse to Masimo and its stockholders, including conflicts resulting from short positions, derivatives, and relationships with current and prospective Masimo competitors or adverse
        litigants.&#8221;&#160; (Exhibit F.)</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">96.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">That purported rationale is a mere pretext, as is illustrated by the fact that neither the Bylaw
        Amendments nor the D&amp;O Questionnaire require incumbent Board members to disclose whether passive investors in their own businesses hold equity interests in &#8220;any principal competitor of the Company or any counterparty to any litigation in which
        the Company is involved.&#8221;&#160; (Bylaws Art. I, &#167;&#167;&#160;1(4)(a)(i)(C), (4)(c)(i)-(iii).)</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">97.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Notably, Director Defendant Mikkelson is an investment manager at Camber, a healthcare-focused
        investment fund.&#160; As Camber itself disclosed in its Form 13-F filed with the SEC, Camber held an investment of more than $55 million in Medtronic plc (&#8220;<u>Medtronic</u>&#8221;)&#8212;and <font style="font-style: italic;">no </font>investment in Masimo&#8212;as of
        March 31, 2022.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">8</sup>&#160; Masimo&#8217;s own annual report describes Medtronic as its &#8220;primary competitor.&#8221;&#160; Yet Mr. Mikkelson was not required to, and did not, disclose</font></div>
    <br>
    <br>
    <hr noshade="noshade" align="left" style="background-color: #000000; border: 0px; height: 1px; width: 2in; margin-left: 0pt; margin-right: auto; color: #000000;">
    <div style="text-align: justify; line-height: 15.95pt; margin-bottom: 12pt; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">8</sup>&#160; Camber, Institutional Investment Manager Holdings Report, Information Table (Form 13F-HR) (May 16, 2022).</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">35</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">this investment to Masimo&#8217;s stockholders.&#160; Nor, for that matter, did he disclose the names or investment holdings of any of Camber&#8217;s limited partners.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">98.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Covered Persons Disclosures are plainly unnecessary, especially considering that the Prior
        Bylaws already included robust disclosure requirements concerning the nominating stockholder, its holdings, and the proposed nominee(s).</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">99.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Under Masimo&#8217;s Prior Bylaws, a nominating stockholder was required to disclose record and
        beneficial ownership information for itself and the underlying beneficial owner of its shares (if any).&#160; (Prior Bylaws Art. I, &#167;&#160;1(4)(c).)&#160; It also was required to disclose &#8220;all information relating to [the proposed nominee(s)] as would be required
        to be disclosed in solicitations of proxies for the election of such nominees as directors pursuant to Regulation 14A under the Exchange Act.&#8221;&#160; (Prior Bylaws Art. I, &#167; 1(4)(a).)&#160; Such information extended to disclosure of &#8220;any material interest,
        direct or indirect, of any director or nominee for election as director who is not or would not be an &#8216;interested person,&#8217;&#160;.&#160;.&#160;.&#160;or Immediate Family Member of the director or nominee, in any transaction, or series of similar transactions&#160;.&#160;.&#160;.&#160;.&#8221;&#160;
        17 C.F.R. &#167;&#160;240.14a-101.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">100.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">In addition, a nominating stockholder was required to disclose &#8220;any other information relating
        to [itself and any underlying beneficial owner of its shares] that would be required to be disclosed in a proxy statement or other filings</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">36</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">required to be made in connection with solicitations of proxies for, as applicable, the proposal and/or for the election of directors in a contested election pursuant to Section 14
      of the Exchange Act.&#8221;&#160; (Prior Bylaws Art. I, &#167; 4(c)(iii).)&#160; Those required disclosures were more than adequate to serve the Board&#8217;s legitimate purpose in vetting director nominees for office.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">101.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Board&#8217;s attempt to add additional disclosure requirements that serve no legitimate
        corporate purpose, on top of what already was a robust advance notice bylaw regime, must be seen for what it is:&#160; an intentional and bad faith attempt to deter, chill and/or prevent investment fund stockholders generally, and Politan in particular,
        from nominating candidates for election to the Board.</font></div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zc51fd61196034a63a412b28a783802db" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 36pt; line-height: 15.95pt; font-size: 14pt; font-style: italic;">2.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt; font-style: italic;">The Bylaw Amendments Extend the Covered Persons Disclosures to Family Members of Covered Persons</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">102.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Bylaw Amendments also provide that a nominating stockholder must disclose to Masimo
        information concerning the investment holdings of &#8220;any Family Member of each Covered Person&#8221; in an extreme departure from both SEC requirements and established norms.&#160; (Bylaws Art. I, &#167; 4(c)(ii).)</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">103.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Bylaws define &#8220;Family Member&#8221; to include not only immediate family members living in a
        person&#8217;s household but also mothers-in-law, fathers-in-law, brothers-in-law and sisters-in-law living <font style="font-style: italic;">outside</font> the person&#8217;s household, as well as &#8220;anyone (other than domestic employees) who shares the</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">37</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">person&#8217;s home,&#8221; which could include roommates and other individuals who are not actually family members of that person.&#160; (Bylaws Art. &#167;&#160;1(4)(ii).)</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">104.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Therefore, under the plain language of the Bylaws, if a stockholder like Politan wished to
        nominate a candidate for election to the Board, it would need to survey the Family Members of both (i) its own limited partners and (ii) any Related Persons (<font style="font-style: italic;">i.e.</font>, any person who has acted in concert with
        the nominating stockholder within the last two years, whether or not regarding Masimo) and disclose any such Family Member&#8217;s investment holdings in a principal competitor or litigation counterparty of the Company.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">105.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Not only is this information practically impossible for a nominating stockholder to collect; it
        also has no bearing on a nominee&#8217;s fitness to serve as a director.&#160; The Prior Bylaws were more than sufficient in requiring disclosure of information regarding interests &#8220;held by members of each such party&#8217;s immediate family sharing the same
        household.&#8221;&#160; (Prior Bylaws Art. I, &#167;&#160;1(4)(c)(ii).)</font></div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z21041f2f86ff46a79440c7aaefe433a7" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 36pt; line-height: 15.95pt; font-size: 14pt; font-style: italic;">3.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt; font-style: italic;">The Bylaw Amendments Require the Nominating Stockholder to Disclose Proprietary Information Concerning Nominations at Other Companies</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">106.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">In another attempt to block investment fund stockholders from nominating candidates for
        election to the Board, the Bylaw Amendments require a nominating stockholder to disclose any &#8220;plans or proposals&#8221; for the nominating stockholder or any Related Person to nominate directors at other public companies</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">38</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">&#8220;within the next 12 months,&#8221; (the &#8220;<u>Future Plans Disclosures</u>&#8221;).&#160; (Bylaws Art. I, &#167;&#160;1(4)(a)(vi).)</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">107.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Typically, investment funds do not publicly disclose their plans and strategies as such
        information is highly confidential and proprietary.&#160; Indeed, many activist funds create value by identifying investment opportunities and strategies for enhancing stockholder value, including by nominating and electing candidates to companies&#8217;
        boards of directors.&#160; Those funds would not be able to successfully implement such a strategy if they were required to telegraph their intention as a pre-condition to nominate candidates for election at a company as much as a year prior to an
        election.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">108.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The disclosure of an activist&#8217;s investment in a company can, and often does, in and of itself,
        create significant value.&#160; For example, over five previous activist situations, public disclosure of an investment by Mr. Koffey has spurred an average increase of 12.4% in the target company&#8217;s stock price and added more than $2 billion on average
        to the market capitalizations of those companies.&#160; That is precisely why investment funds treat their future plans as highly confidential.&#160; The Future Plans Disclosures would require investment funds to forego that value in exchange for the right
        to nominate candidates for election to Masimo&#8217;s Board.&#160; As such, the Bylaw Amendments chill activists from nominating candidates for election</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">39</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">to Masimo&#8217;s Board by forcing them to choose between making a nomination and risking returns on future investment opportunities.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">109.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Relatedly, the Bylaw Amendments require a nominating stockholder to disclose any proposals or
        nominations by the nominating stockholder or any Related Person at other public companies in the last 36 months, &#8220;whether or not such&#160;.&#160;.&#160;.&#160;nomination was publicly disclosed,&#8221; (the &#8220;<u>Past Proposals Disclosures</u>&#8221;).&#160; (Bylaws Art. I,
        &#167;&#160;1(4)(a)(vii).)&#160; That disclosure requirement, too, is aimed directly at the investment fund business model and intended to discourage investment fund stockholders from nominating candidates.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">110.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">As the Past Proposals Disclosures recognize, situations may arise in which a stockholder&#8217;s
        prior proposal or nomination was never publicly disclosed.&#160; In those situations, the stockholder and the company may enter into settlement agreements that address issues like board representation, corporate governance changes and other initiatives
        to enhance stockholder value, and that impose restrictions on the investor.&#160; Such settlement agreements sometimes contain strict confidentiality provisions which may prevent a nominating stockholder from being able to comply with the Past Proposals
        Disclosures requirement.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">111.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Board has no legitimate need for the information that a nominating stockholder must
        disclose under the Future Plans Disclosures or the Past Proposals Disclosures.&#160; That information has no bearing whatsoever on the fitness</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">40</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">of a stockholder&#8217;s director nominees and provides neither the Board nor stockholders with material information regarding a nominating stockholder or its investment in Masimo.</div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z625c5db16c794e81922a904c5a3a1efd" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 36pt; line-height: 15.95pt; font-size: 14pt; font-style: italic;">4.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt; font-style: italic;">The Bylaw Amendments Require Disclosure of a Broad Category of Agreements and Arrangements Involving the Nominating Stockholder and a Broad Range of
                Potential Counterparties</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">112.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Bylaw Amendments also operate to chill the stockholder franchise by mandating extensive
        disclosures about &#8220;agreements&#8221; or &#8220;understandings&#8221; with and among &#8220;Covered Persons,&#8221; &#8220;Related Persons,&#8221; and unascertainable others (the &#8220;<u>Agreements or Understandings Disclosures</u>&#8221;).&#160; (Bylaws Art. I, &#167;&#160;1(4)(a)(iii), (v).)</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">113.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The scope of the Agreements or Understandings Disclosures goes far beyond what is required
        under the federal securities laws, covering any agreement or understanding regarding, vaguely, &#8220;any subject matter that could reasonably be determined to be material in the Nominating Person&#8217;s solicitation of stockholders (including, without
        limitation, matters of social, labor, environmental, and governance policy), regardless of whether such agreement, arrangement or understanding relates specifically to [Masimo].&#8221;&#160; (Bylaws Art. I, &#167;&#160;1(4)(a)(iv), (v).)</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">114.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Equally troubling is the wide-ranging yet vaguely defined group of individuals or entities
        whose agreements and understandings must be disclosed.&#160; As noted, the term &#8220;Related Persons&#8221; includes persons with whom the nominating</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">41</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">stockholder has acted &#8220;in concert&#8221; &#8220;during the prior two years&#8221; with respect to matters, &#8220;whether or not specific to [Masimo],&#8221; that would be material to the solicitation of
      stockholders.&#160; (Bylaws Art. I, &#167;&#160;1(9)(g).)&#160; It is anybody&#8217;s guess how the Company might interpret such a vague provision.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">115.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">In short, a nominating stockholder is left to speculate which &#8220;agreements&#8221; or &#8220;undertakings,&#8221;
        with which counterparties, must be disclosed.&#160; It is impossible for a nominating stockholder to ascertain whether it has complied with the Agreements or Understandings Disclosures requirements, and the Board has unfettered (and arbitrary)
        discretion to determine whether the disclosures tendered are acceptable.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">116.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Indeed, because the Agreements or Understandings Disclosures require such a broad range of
        information concerning (i) potential agreements (<font style="font-style: italic;">i.e.</font>, agreements or understandings regarding &#8220;any subject matter that could reasonably be determined to be material in the Nominating Person&#8217;s solicitation of
        stockholders&#160;.&#160;.&#160;.&#160;regardless of whether such agreement, arrangement or understanding relates specifically to [Masimo]&#8221;) and (ii) the counterparties thereto (<font style="font-style: italic;">i.e.</font>, anyone with whom the nominating stockholder
        acted &#8220;in concert&#8221; during the previous two years regardless of whether such coordination involved Masimo), a nominating stockholder can never be sure that it has satisfied those disclosure requirements.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">42</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">117.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">In addition, the Agreements or Understandings Disclosures give Masimo <font style="font-style: italic;">carte blanche</font> to conduct a fishing expedition under the guise of determining whether the information it desires &#8220;could reasonably be determined to be material&#8221; to stockholders.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">118.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Finally, because the Agreements or Understandings Disclosures have no boundaries, the Board is
        free to apply different standards&#8212;or no standards at all&#8212;to different nominating stockholders when determining whether a stockholder has complied with the disclosure requirements.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">119.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Like the Covered Persons Disclosures, the Agreements or Understandings Disclosures serve no
        legitimate purpose because the Prior Bylaws already had ample disclosures in place to allow Masimo to obtain necessary information in this regard.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">120.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">For instance, the Prior Bylaws (Prior Bylaws Art. I, &#167;&#160;1(4)) included disclosure requirements
        concerning transactions with related persons, specifically requesting &#8220;any other information regarding the transaction or the related person in the context of the transaction that is material to investors in light of the circumstances of the
        particular transaction.&#8221;&#160; 17 C.F.R. &#167;&#160;229.404.</font></div>
    <div>
      <table cellspacing="0" cellpadding="0" id="za88e916ee65648b1b26554ee0dab0bf8" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 36pt; line-height: 15.95pt; font-size: 14pt; font-style: italic;">5.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt; font-style: italic;">The Bylaw Amendments Require Disclosure of Information Regarding Any Stockholder Known to Support the Nomination, Whether or Not</div>
            </td>
          </tr>

      </table>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">43</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; margin-left: 72pt; line-height: 15.95pt; margin-bottom: 12pt; font-size: 14pt; font-style: italic;">Such Other Stockholder Has an Agreement With the Nominating Stockholder Regarding the Nomination</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">121.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Bylaw Amendments also unreasonably require a nominating stockholder to disclose the
        identities of any other stockholder known to support the nomination.&#160; Specifically, the Bylaw Amendments require the disclosure of the names, addresses, and shares held by any stockholder &#8220;known&#160;.&#160;.&#160;.&#160;to support such nomination&#8221; (the &#8220;<u>Supporting
          Stockholder Disclosures</u>&#8221;).&#160; (Bylaws Art. I, &#167;&#160;1(4)(a)(ii).)</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">122.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Like the Agreements or Understandings Disclosures, the Supporting Stockholder Disclosures are
        ill-defined and unduly vague.&#160; By their terms, the Supporting Stockholder Disclosures require a nominating stockholder to disclose not just any other stockholders that have provided <font style="font-style: italic;">financial</font> support for a
        nomination but also those that have expressed support in <font style="font-style: italic;">any </font>form.&#160; There is a marked difference between financial support and supporting a position in a proxy contest.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">123.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Indeed, on October 17, 2022, Politan asked Masimo to confirm that &#8220;Politan would only be
        required to disclose instances where a stockholder has given material support in the form of financial support, a voting commitment or</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">44</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">similar arrangement.&#8221;<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">9</sup>&#160; (Exhibit G.)&#160; By letter dated October 19, 2022, Masimo expressly rejected any such limitation, stating that the Supporting Stockholder
      Disclosures requirement &#8220;is not so limited&#8221; and &#8220;plainly requires the disclosure of any stockholders known to &#8216;support such nomination,&#8217; and <font style="font-style: italic;">does not contain a materiality qualifier or limit the required disclosure
        to any particular &#8220;forms&#8221; of support</font>.&#8221;&#160; (Exhibit H, at 5) (emphasis added).</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">124.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">As drafted, the Supporting Stockholder Disclosures are so broad as to be virtually unbounded.&#160;
        It is impossible for a nominating stockholder to determine whether, for instance, a casual comment by a stockholder that she hopes the nominating stockholder&#8217;s candidate wins or wishing the stockholder &#8220;good luck&#8221; would trigger the disclosure
        requirement.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">125.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Moreover, requiring early disclosure of stockholder support for a nomination would
        significantly chill stockholder communications.&#160; When determining whether to commence a proxy contest, it is not uncommon for a nominating stockholder to gauge support by communicating with other stockholders to determine whether other stockholders
        share their views.&#160; In connection with those preliminary discussions, other stockholders sometimes express &#8220;support&#8221; for the</font></div>
    <br>
    <br>
    <hr noshade="noshade" align="left" style="background-color: #000000; border: 0px; height: 1px; width: 2in; margin-left: 0pt; margin-right: auto; color: #000000;">
    <div style="text-align: justify; line-height: 15.95pt; margin-bottom: 12pt; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">9</sup>&#160; Politan does not challenge the Supporting Stockholder Disclosures to the extent they require disclosure of material support in the form of
      financial support, a voting commitment or similar arrangement.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">45</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">nominating stockholder but do not commit to voting for the stockholder&#8217;s nominee or proposal, as often such support is tentative, subject to change and requires internal approval.&#160;
      In addition, certain stockholders fear retribution by the company if they are seen to be in league with a nominating stockholder.&#160; For those reasons, among others, if such preliminary and tentative discussions of support would be subject to
      disclosure, many stockholders would be expected to refrain from having such discussions out of concern for internal or external repercussions.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">126.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Thus, the Supporting Stockholder Disclosures would chill important and permitted communications
        among stockholders&#8212;communications that the SEC has expressly encouraged&#8212;and facilitate the harassment of any potential supporters of a stockholder&#8217;s efforts to nominate new directors.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">127.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Given the existing requirement under the federal securities laws to disclose the source of
        recommendations for a nominee, <font style="font-style: italic;">see</font> 17&#160;C.F.R. &#167;&#160;229.407(c), the Supporting Stockholder Disclosures are unnecessary and plainly are designed to serve as an impediment to nominations.</font></div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z8678e8fbaf544a328f5656884abd1dd5" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; line-height: 15.95pt; font-size: 14pt; font-weight: bold;">G.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt; font-weight: bold;">The Bylaw Amendments Are Particularly Inequitable Given the New SEC Rule on Universal Proxy Cards</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">128.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">It would be particularly inequitable to apply the Bylaw Amendments in the upcoming proxy season
        given the SEC&#8217;s recent adoption of rules implementing the use of &#8220;universal proxy cards.&#8221;&#160; The new universal proxy rules</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">46</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">apply to all stockholder meetings involving contested director elections held after August 31, 2022.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">129.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Under new SEC Rule 14a-19, the universal proxy card must include all candidates nominated by
        management and stockholders for election at the upcoming annual meeting.&#160; If the Board is permitted to enforce the disclosures required by the Bylaw Amendments, Politan would be forced to solicit proxies on cards that include all of Masimo&#8217;s
        candidates, while Masimo could refuse to include any of Politan&#8217;s candidates on its cards.&#160; Such a circumstance would both tilt the playing field in favor of the incumbent directors and lead to stockholder confusion.</font></div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z5cff44f145464f758657b0ca17aa2468" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; line-height: 15.95pt; font-size: 14pt; font-weight: bold;">H.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt; font-weight: bold;">The Board Continues to Block Politan&#8217;s Attempt to Nominate Stockholders to the Board</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">130.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">On September 20, 2022, Politan sent Masimo a letter requesting that the Board either amend
        Masimo&#8217;s Bylaws to eliminate the onerous requirements or revert back to the Prior Bylaws in effect prior to the Bylaw Amendments.&#160; (Exhibit I.)</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">131.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Masimo responded to Politan on September 28, 2022, declining to do either.&#160; (Exhibit F.)&#160;
        Despite adopting the Bylaw Amendments and the poison pill <font style="font-weight: bold; font-style: italic;">just a week</font> after Politan expressed interest in Board representation, Masimo now claims that the Bylaw Amendments were adopted
        after &#8220;good faith and thoughtful consideration in response to the SEC&#8217;s recent amendments to the proxy rules,</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">47</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">including Rule 14a-19&#160;.&#160;.&#160;.&#160;.&#8221;<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">10</sup>&#160; But the timing of the adoption of the Bylaw Amendments and the poison pill belies Masimo&#8217;s self-serving claim.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">132.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Notably, Masimo has failed to provide any justification for the far-reaching provisions in the
        Bylaw Amendments that would force Politan to disclose, among other things, proprietary and confidential information concerning (i) the identities and investments of its own limited partners and (ii) its plans or proposals relating to nominations at
        other public companies.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">133.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Board&#8217;s refusal to amend the facially invalid Bylaws serves no legitimate corporate
        interest and has no purpose other than to maintain the Director Defendants in office, irrespective of the will of stockholders.</font></div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z037053bdd98d4e5fa227e83a80bbd82b" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; line-height: 15.95pt; font-size: 14pt; font-weight: bold;">I.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt; font-weight: bold;">Masimo Refuses to Confirm That Politan&#8217;s Form of Notice Is Sufficient to Allow Politan to Nominate a Candidate or Disable the Director Change of
                Control Provision</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">134.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Masimo held its 2022 Annual Meeting on May 26, 2022 and historically holds its Annual Meetings
        in that timeframe.&#160; Also, under Masimo&#8217;s Bylaws, stockholders wishing to nominate candidates for election to Masimo&#8217;s Board at the 2023 Annual Meeting likely must do so between January 28, 2023 and February 27, 2023.</font></div>
    <br>
    <br>
    <hr noshade="noshade" align="left" style="background-color: #000000; border: 0px; height: 1px; width: 2in; margin-left: 0pt; margin-right: auto; color: #000000;">
    <div style="text-align: justify; line-height: 15.95pt; margin-bottom: 12pt; font-size: 14pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">10</sup>&#160; To be clear, amendments to the following Bylaw provisions address the SEC&#8217;s recent amendments to the proxy rules:&#160; Bylaws &#167;&#167; 1(3)(d), 1(4)(d),
      1(4)(e).&#160; Politan does not challenge those Bylaw Amendments in this action.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">48</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">135.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">In an effort to determine whether the Board would accept a nomination, on October 9, 2022,
        Politan submitted a form of nomination notice, a completed questionnaire and related materials (collectively, the &#8220;<u>Politan Form of Notice</u>&#8221;) which presented Mr. Koffey as a nominee for election to the Board at the 2023 Annual Meeting.&#160;
        (Exhibit J.)&#160; The Politan Form of Notice contained extensive information about Politan, Mr. Koffey, and Politan&#8217;s investment in Masimo.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 12pt;">136.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">While Politan declined to disclose the identities of its limited partners, it provided
        substantial information in an effort to assuage any concerns that Masimo might have.&#160; Among other things, it advised that the Covered Persons are all passive investors in Politan&#8217;s fund and Politan does not coordinate its activities with them.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 12pt;">137.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Further, Politan disclosed that the Covered Persons are reputable family offices, pension
        funds, endowments and sovereign entities, many of which control tens, if not hundreds, of billions of dollars of capital and their investments in Politan represent a relatively small portion of their investment portfolios.&#160; Politan also represented
        that there are no secret plans or agendas&#8212;Politan&#8217;s goal is to increase the value of its investment in Masimo for the benefit of itself, its investors and other stakeholders of Masimo.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">49</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">138.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Finally, Politan asked, if it were to deliver an actual notice of nomination in the same form
        as the Politan Form of Notice during Masimo&#8217;s nomination window under its Bylaws, with signatures affixed, whether (i) Masimo would accept such notice as valid and permit Politan to nominate Mr. Koffey as a candidate for election to the Board at
        the 2023 Annual Meeting, (ii) the Board would not find any deficiency in such form of notice, and (iii) the Board is aware of any other reason that would provide it with a basis to reject such nomination.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt; font-weight: normal;">139.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">On October 19, 2022, Masimo refused to confirm that it would not reject
        Politan&#8217;s nomination, citing alleged &#8220;concerns about the material accuracy and completeness of certain of the information contained in the [Politan Form of Notice], as well as with [its] clear omissions.&#8221;&#160; (Exhibit H.)&#160; In particular, Masimo
        faulted Politan for failing to comply with the inequitable Bylaw Amendments that Politan challenges in this action&#8212;<font style="font-style: italic;">i.e.</font>, (i) not disclosing &#8220;the identity of its significant (<font style="font-style: italic;">i.e.</font>,
        5%+) limited partners,&#8221; (ii) limiting its disclosure of proposals or nominations by Politan at other public companies in the last 36 months to those that had been publicly disclosed, (iii) not disclosing any plans or proposals to nominate directors
        at other public companies in the next 12 months, and (iv) limiting its disclosure of other stockholders that support Politan&#8217;s nomination to stockholders providing financial support, a voting commitment or similar arrangement.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">50</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt; font-weight: normal;">140.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Furthermore, on October 17, 2022, Politan requested that the Board agree
        to disable the Director Change of Control Provision to permit Masimo&#8217;s stockholders to elect Politan&#8217;s nominees without triggering massive payments to Mr. Kiani.&#160; (Exhibit G.)&#160; The Board refused to do so, claiming that the Employment Agreement was
        the product of &#8220;extensive arms-length negotiations between representatives of Masimo&#8217;s independent directors and Mr. Kiani&#8221; and that the Board lacked the authority to unilaterally waive the Director Change of Control Provision.&#160; (Exhibit H.)</font></div>
    <div style="text-align: center; line-height: 15.95pt; margin-bottom: 12pt; font-size: 14pt; font-weight: bold;"><u>STANDARD OF REVIEW</u></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">141.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">As set forth above, the Board adopted the Bylaw Amendments and the poison pill only days after
        Mr. Koffey expressed his interest in obtaining representation on Masimo&#8217;s Board.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">142.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Bylaw Amendments serve no legitimate corporate purpose.&#160; Instead, the Board adopted the
        Bylaw Amendments for the sole or primary purpose of precluding investment fund stockholders, particularly Politan, from exercising their fundamental right to nominate individuals for election to Masimo&#8217;s Board, thereby entrenching the Board in
        office.&#160; Indeed, Masimo has expressly admitted that the Board adopted the Bylaw Amendments in direct response to Politan&#8217;s expression of interest in obtaining Board representation.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">51</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">143.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Accordingly, the Board&#8217;s adoption of the Bylaw Amendments is &#8220;presumptively inequitable and
        will be invalidated, unless the directors are able to rebut that presumption by showing a compelling justification for their actions.&#8221;&#160; <font style="font-style: italic;">Hubbard v. Hollywood Park Realty Enters., Inc</font>., 1991 WL 3151, at *8
        (Del. Ch. Jan. 14, 1991) (citing <font style="font-style: italic;">Blasius Indus., Inc. v. Atlas Corp.</font>, 564 A.2d 651 (Del. Ch. 1988)).</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">144.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Board cannot make any such showing.&#160; The Bylaw Amendments all but abrogate an investment
        fund stockholder&#8217;s right to nominate candidates for election to the Board.&#160; They require nominating stockholders to disclose, among other things, both the identities and investments of their own passive outside investors and the nominating
        stockholder&#8217;s future strategic plans to nominate candidates at other public companies, which are closely guarded proprietary information tantamount to trade secrets.&#160; That information is wholly divorced from the proper purpose of advance notice
        bylaws, which is to permit orderly election contests by giving companies fair warning so they have time to respond to stockholder nominations.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">145.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Nor does the Board need any such information to determine whether a nominee is subject to
        &#8220;undisclosed conflicts of interest adverse to Masimo and its stockholders,&#8221; as is illustrated by the fact that the current Board members are not subject to the broad disclosure requirements set forth in the Bylaw Amendments.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">52</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">146.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Moreover, even if the <font style="font-style: italic;">Blasius </font>standard does not
        apply here, the Board&#8217;s actions are nevertheless invalid under <font style="font-style: italic;">Schnell v. Chris-Craft Indus., Inc.</font>, 285 A.2d 437, 439 (Del. 1971).&#160; <font style="font-style: italic;">Schnell</font> recognizes that any
        attempt to &#8220;utilize the corporate machinery and the Delaware Law for the purpose of perpetuating [oneself] in office&#8221; by &#8220;obstructing the legitimate efforts of dissident stockholders in the exercise of their rights to undertake a proxy contest&#8221;
        must be denied because those are &#8220;inequitable purposes, contrary to established principles of corporate democracy.&#8221;&#160; <font style="font-style: italic;">Id.</font></font></div>
    <div style="text-align: center; line-height: 15.95pt; font-size: 14pt; font-weight: bold;"><u>COUNT I</u></div>
    <div style="text-align: center; line-height: 31.9pt; font-size: 14pt; font-weight: bold;">(Declaratory Judgment &#8211; Bylaw Amendments)</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">147.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Plaintiffs repeat and reallege the preceding paragraphs as if fully set forth herein.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">148.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Covered Persons Disclosures, the Family Member Disclosures, the Future Plans Disclosures,
        the Past Proposals Disclosures, the Agreements or Understandings Disclosures, and the Supporting Stockholder Disclosures (collectively, the &#8220;<u>Invalid Bylaw Amendments</u>&#8221;) are invalid because they improperly restrict stockholder rights, impose
        unreasonable conditions on the ability of stockholders to nominate candidates for election to the Board, and violate public policy.&#160; As written, the Invalid Bylaw Amendments permit Masimo to</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">53</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">manipulate the electoral process to subvert stockholder rights and serve only to entrench the incumbent Board.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">149.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">In particular, among other things:</font></div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z5bd4a54c908b44d9a4489cba260bf454" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 135pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 108pt; line-height: 15.95pt; font-size: 14pt;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;">The Covered Persons Disclosures require an investment fund nominating stockholder to disclose highly sensitive, and often impossible to obtain, information concerning
                the identities and investments of its own limited partners;</div>
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;"> <br>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z3e4f1ad62d674d3faa3204e0eb3b8161" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 135pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 108pt; line-height: 15.95pt; font-size: 14pt;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;">The Family Member Disclosures extend the Bylaw Amendments&#8217; broad disclosure provisions to a wide-range of individuals, including the mothers-in-law, fathers-in-law,
                brothers-in-law, sisters-in-law, and perhaps even roommates, of any Covered Person (which, in the case of investment fund nominating stockholders, includes the stockholder&#8217;s investors);</div>
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;"> <br>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z99b78f3da9a94eec90f4a8470bdb8a45" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 135pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 108pt; line-height: 15.95pt; font-size: 14pt;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;">The Future Plans Disclosures require a nominating stockholder to disclose highly confidential and proprietary information concerning future plans and strategies to
                nominate directors for election at other public companies;</div>
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;"> <br>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z5ba3923649664a169d2a07789e9ac93c" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 135pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 108pt; line-height: 15.95pt; font-size: 14pt;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;">The Past Proposals Disclosures may require a nominating stockholder to disclose non-public settlements and other agreements with other public companies in violation of
                confidentiality obligations;</div>
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;"> <br>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z4b9db54b8ed9487a9086a963b3c111a7" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 135pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 108pt; line-height: 15.95pt; font-size: 14pt;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;">The Agreements or Understandings Disclosures require nominating stockholders to disclose vaguely-defined &#8220;agreements&#8221; or &#8220;understandings&#8221; with a wide-ranging, amorphous
                group of individuals or entities; and</div>
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;"> <br>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z3a3d8ab02a134056b6e9cec7c9ff06c4" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 135pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 108pt; line-height: 15.95pt; font-size: 14pt;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;">The Supporting Stockholder Disclosures require the nominating stockholder to identify any other stockholder that supports the nomination, which would chill important and
                permitted communications among stockholders and facilitate the harassment of any potential supporters of a stockholder&#8217;s efforts to nominate new directors.</div>
              <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;"> <br>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">54</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">150.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Director Defendants&#8217; primary purpose in adopting the Invalid Bylaw Amendments was to
        preclude Plaintiffs from nominating candidates for election to the Board and to interfere with the ability of stockholders to nominate and vote for directors other than the incumbents.&#160; Indeed, Masimo has admitted as much.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">151.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Plaintiffs have no adequate remedy at law.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">152.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Plaintiffs are entitled to a declaration that the Invalid Bylaw Amendments are unlawful and
        Politan need not comply with such disclosure requirements to nominate candidates to stand for election at Masimo&#8217;s next annual meeting of stockholders.</font></div>
    <div style="text-align: center; line-height: 15.95pt; font-size: 14pt; font-weight: bold;"><u>COUNT II</u></div>
    <div style="text-align: center; line-height: 15.95pt; margin-bottom: 12pt; font-size: 14pt; font-weight: bold;">(Breach of Fiduciary Duties Against the Director Defendants &#8211;<br>
      Bylaw Amendments)</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">153.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Plaintiffs repeat and reallege the preceding paragraphs as if fully set forth herein.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">154.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Director Defendants owe Masimo&#8217;s stockholders&#8212;including Politan&#8212;the uncompromising
        fiduciary duties of care and loyalty.&#160; Those fiduciary duties preclude the Director Defendants from taking any action to favor their own interests ahead of the interests of Masimo and its stockholders.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">55</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">155.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Director Defendants have abused their positions and misused the corporate machinery to
        impede the exercise of the stockholder franchise and to entrench themselves in office.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">156.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">In breach of their fiduciary duties, the Director Defendants approved the Invalid Bylaw
        Amendments, which place inequitable and unreasonable burdens upon stockholders seeking to nominate director candidates.&#160; The Invalid Bylaw Amendments have no legitimate corporate purpose and are instead designed to thwart nominations to replace
        incumbent directors and stymie stockholders from exercising their franchise.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">157.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Director Defendants had no justification, much less a reasonable or compelling
        justification, to adopt the Invalid Bylaw Amendments mere days after the meeting between Mr. Koffey and Mr. Kiani in which Politan expressed an interest in obtaining representation on Masimo&#8217;s Board.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">158.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Director Defendants&#8217; primary purpose in adopting the Invalid Bylaw Amendments was to
        preclude Plaintiffs from nominating candidates for election to the Board and to interfere with the ability of stockholders to nominate and vote for directors other than the incumbents.&#160; Masimo has admitted as much.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">159.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Director Defendants are acting unlawfully and in bad faith to entrench themselves by
        blocking Politan from presenting alternative candidates to stockholders, consistent with Plaintiffs&#8217; franchise rights.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">56</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">160.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Defendants&#8217; misuse of the corporate machinery to impede the exercise of the shareholders&#8217;
        franchise and entrench themselves in office constitutes a clear violation of their fiduciary duties under Delaware law.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">161.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Plaintiffs have no adequate remedy at law.</font></div>
    <div style="text-align: center; line-height: 15.95pt; font-size: 14pt; font-weight: bold;"><u>COUNT III</u></div>
    <div style="text-align: center; line-height: 15.95pt; margin-bottom: 12pt; font-size: 14pt; font-weight: bold;">(Breach of Fiduciary Duties Against the Director Defendants &#8211;<br>
      Director Change of Control Provision)</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">162.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Plaintiffs repeat and reallege the preceding paragraphs as if fully set forth herein.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">163.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Director Defendants owe Masimo&#8217;s stockholders&#8212;including Politan&#8212;the uncompromising
        fiduciary duties of care and loyalty.&#160; Those fiduciary duties preclude the Director Defendants from taking any action to favor their own interests ahead of the interests of Masimo and its stockholders.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">164.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">The Director Defendants have refused to disable the Director Change of Control Provision in the
        Employment Agreement to prevent Masimo from becoming obligated to make massive severance payments to Mr. Kiani in the event that two Politan nominees are elected to the Board.&#160; The Board has done so for the primary purpose of obstructing the
        ability of Masimo stockholders to remove the Director Defendants from office.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">165.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">To the extent that the Employment Agreement does not provide the Director Defendants with the
        ability to disable the Director Change of Control</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">57</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: justify; line-height: 31.9pt; font-size: 14pt;">Provision, the Director Change of Control Provision is invalid and unenforceable under Delaware law.</div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">166.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">As a result of the Director Defendants&#8217; foregoing breaches, Masimo stockholders will be
        deprived of their opportunity to decide whether to support Politan&#8217;s nominees free from the coercive effects of hundreds of millions of dollars in severance payments to Mr. Kiani.&#160; <font style="font-style: italic;">See</font>&#160;<font style="font-style: italic;">Marcato International Master Fund, Ltd. v. John M. Gibbons, et al. [Deckers]</font>, C.A. No. 2017-0751-JTL, transcript at 46-47, 57-58 (Del. Ch. May 25, 2018; filed June 22, 2018) (awarding corporate benefit fees to
        plaintiffs who successfully challenged directors&#8217; attempt to stand on similar &#8220;continuing directors&#8221; provision of compensation agreement in order to accelerate executive compensation upon election of director nominated by plaintiff).</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">167.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Plaintiffs are entitled to a declaration that the Director Defendants breached their fiduciary
        duties.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">168.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Plaintiffs are entitled to an injunction requiring the Board to disable the Director Change of
        Control Provision.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">169.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">To the extent that the Board lacks the ability to disable the Director Change of Control
        Provision, the Court should declare the Director Change of Control Provision void and unenforceable.</font></div>
    <div style="line-height: 31.9pt; text-align: justify; text-indent: 72pt;"><font style="font-size: 14pt;">170.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 14pt;">Plaintiffs have no adequate remedy at law.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">58</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <div style="text-align: center; line-height: 15.95pt; margin-bottom: 12pt; font-size: 14pt; font-weight: bold;"><u>PRAYER FOR RELIEF</u></div>
    <div style="text-align: justify; text-indent: 72pt; line-height: 31.9pt; font-size: 14pt;">WHEREFORE, Plaintiffs respectfully request the following relief:</div>
    <table cellspacing="0" cellpadding="0" id="z607aa675a8924cabaedb08ed592be972" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 72pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; font-size: 14pt;">(i)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 14pt;">Declaring that the Invalid Bylaw Amendments are unenforceable;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z490ebd5a13314b3ab4509f54054073f8" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 72pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; font-size: 14pt;">(ii)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 14pt;">Declaring that the Director Defendants breached their fiduciary duties by adopting the Bylaw Amendments and the poison pill;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="za71d848e01254898acfd5c557f39e3f7" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 72pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; font-size: 14pt;">(iii)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 14pt;">Declaring that the Director Defendants breached their fiduciary duties by refusing to disable the Director Change of Control Provision;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="ze711740d3b6f449ba000c922a7af7485" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 72pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; font-size: 14pt;">(iv)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 14pt;">Ordering the Board to disable the Director Change of Control Provision and, to the extent the Board lacks the ability to disable the Director Change of Control Provision, declaring the Director Change of Control
              Provision void and unenforceable;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z1db80be211ba489d851e01c1b1f6d5cb" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 72pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; font-size: 14pt;">(v)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 14pt;">Enjoining Masimo and the Board from taking any actions to prevent Politan from exercising its rights in accordance with Masimo&#8217;s Prior Bylaws to nominate directors;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z5aba8c2e8eda47509cedb33d60beb3d5" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 72pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; font-size: 14pt;">(vi)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 14pt;">Awarding Plaintiffs their fees, costs, and expenses, including their attorneys&#8217; fees and costs, incurred in connection with this action; and</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z11d59a7e3a1b4a50a98a92b27feb2115" class="DSPFListTable" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 72pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; font-size: 14pt;">(vii)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 14pt;">Granting Plaintiffs such other and further relief as the Court deems just and proper.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 15.95pt; margin-top: 12pt;"><br style="line-height: 15.95pt;">
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageFooter">
        <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">59</font></div>
        <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
        </div>
      </div>
    </div>
    <div style="line-height: 15.95pt;"><br style="line-height: 15.95pt;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z6633cc144b96467b8233108af544ddba" style="font-family: Arial, Helvetica, sans-serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 48.02%; vertical-align: top;">
            <div style="line-height: 15.95pt;"><font style="line-height: 15.95pt;">&#160;</font></div>
            <div style="line-height: 31.9pt;"><font style="line-height: 31.9pt;">&#160;</font></div>
            <div style="line-height: 15.95pt;"><font style="line-height: 15.95pt;">&#160;</font></div>
            <div style="line-height: 15.95pt;"><font style="line-height: 15.95pt;">&#160;</font></div>
            <div style="line-height: 15.95pt; font-size: 14pt;">OF COUNSEL:</div>
            <div style="line-height: 15.95pt;"><font style="line-height: 15.95pt;">&#160;</font></div>
            <div style="line-height: 15.95pt; font-size: 14pt;">Michael E. Swartz</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">Frank W. Olander</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">SCHULTE ROTH &amp; ZABEL LLP</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">919 Third Avenue</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">New York, NY&#160; 10022</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">(212) 756-2000</div>
            <div style="line-height: 15.95pt;"><font style="line-height: 15.95pt;">&#160;</font></div>
            <div style="line-height: 15.95pt;"><font style="line-height: 15.95pt;">&#160;</font></div>
          </td>
          <td style="width: 51.98%; vertical-align: top;">
            <div style="line-height: 15.95pt; font-size: 14pt;">MORRIS, NICHOLS, ARSHT &amp; </div>
            <div style="line-height: 15.95pt; font-size: 14pt;">TUNNELL LLP</div>
            <div style="line-height: 15.95pt;"><font style="line-height: 15.95pt;">&#160;</font></div>
            <div style="line-height: 15.95pt;"><font style="line-height: 15.95pt;">&#160;</font></div>
            <div style="line-height: 15.95pt;"><font style="line-height: 15.95pt;">&#160;</font></div>
            <div style="line-height: 15.95pt; font-size: 14pt;"><u>/s/ </u><font style="font-style: italic;"><u>John P. DiTomo&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u></font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
            </div>
            <div style="line-height: 15.95pt; font-size: 14pt;">John P. DiTomo (#4850)</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">Alexandra M. Cumings (#6146)</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">Sahba Saravi (#6931)</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">1201 N. Market Street</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">Wilmington, DE&#160; 19899-1347</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">(302) 658-9200</div>
            <div style="line-height: 15.95pt;"><font style="line-height: 15.95pt;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 48.02%; vertical-align: top;">
            <div style="line-height: 15.95pt;"><font style="line-height: 15.95pt;">&#160;</font></div>
            <div style="line-height: 15.95pt;"><font style="line-height: 15.95pt;">&#160;</font></div>
            <div style="line-height: 15.95pt;"><font style="line-height: 15.95pt;">&#160;</font></div>
            <div style="line-height: 15.95pt; font-size: 14pt;">OF COUNSEL:</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">Richard Brand</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">Nishal R. Ramphal</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">CADWALADER, WICKERSHAM &amp; TAFT LLP</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">200 Liberty Street,</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">New York, NY&#160; 10281</div>
            <div style="line-height: 15.95pt; font-size: 14pt;">(212) 504-6000</div>
            <div style="line-height: 15.95pt;"><font style="line-height: 15.95pt;">&#160;</font></div>
          </td>
          <td style="width: 51.98%; vertical-align: top;">
            <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;">YOUNG CONAWAY STARGATT</div>
            <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;">&#160;&#160;&#160;&amp; TAYLOR, LLP</div>
            <div style="line-height: 15.95pt;"><font style="line-height: 15.95pt;">&#160;</font></div>
            <div style="text-align: justify; line-height: 15.95pt;"><font style="font-size: 14pt; font-style: italic;"><u>/s/ </u><u>Martin S. Lessner&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u></font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
            </div>
            <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;">Martin S. Lessner (#3109)</div>
            <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;">Tammy L. Mercer (#4957)</div>
            <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;">Alberto E. Ch&#225;vez (#6395)</div>
            <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;">Rodney Square</div>
            <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;">1000 North King Street</div>
            <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;">Wilmington, Delaware 19801</div>
            <div style="text-align: justify; line-height: 15.95pt; font-size: 14pt;">(302) 571-6600</div>
            <div style="line-height: 15.95pt;"><font style="line-height: 15.95pt;">&#160;</font></div>
            <div style="margin-left: 12.6pt; line-height: 15.95pt; font-size: 14pt; font-style: italic;">Attorneys for Plaintiffs</div>
            <div style="line-height: 15.95pt;"><font style="line-height: 15.95pt;">&#160;</font></div>
          </td>
        </tr>

    </table>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 15.95pt; margin-top: 12pt; font-size: 14pt;">October 21, 2022</div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 15.95pt; margin-top: 12pt; font-size: 14pt;"> <br>
    </div>
    <div class="BRPFPageFooter">
      <div style="text-align: center; line-height: 15.95pt; font-size: 14pt;"><font class="BRPFPageNumber">60</font></div>
      <div style="line-height: 15.95pt; margin-bottom: 12pt;"><br style="line-height: 15.95pt;">
      </div>
      <div style="line-height: 15.95pt; margin-bottom: 12pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
    </div>
  </div>
  <div> <br>
  </div>
  <div> <br>
  </div>
  <div> <br>
  </div>
  <div> <br>
  </div>
  <div> <br>
  </div>
  <div> <br>
  </div>
  <div> <br>
  </div>
  <br>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image00002.jpg
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" %D 6\# 2(  A$! Q$!_\0
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MK7_/AIWY/_\ %4?\+?UK_GPT[\G_ /BJ\VHH#VT^YZ3_ ,+?UK_GPT[\G_\
MBJ/^%OZU_P ^&G?D_P#\57FU% >VGW/2?^%OZU_SX:=^3_\ Q5'_  M_6O\
MGPT[\G_^*KS:B@/;3[GI/_"W]:_Y\-._)_\ XJC_ (6_K7_/AIWY/_\ %5YM
M10'MI]STG_A;^M?\^&G?D_\ \51_PM_6O^?#3OR?_P"*KS:I+:%KFYB@CQOE
M<(N3@9)P* ]M/N>B_P#"W]:_Y\-._)__ (JC_A;^M?\ /AIWY/\ _%5SS>!=
M97Q(NB%;?[8T/GAO,/E[/KCUXZ5S]Y9S6EW<V\BEGMY&CD* LH(.#S04ZE5;
ML]!_X6_K7_/AIWY/_P#%4?\ "W]:_P"?#3OR?_XJO-]C%"X1B@ZMM./SJQ=6
M;0"$K)'-YL8DQ#EMF>S<<&@GVU3N>@?\+?UK_GPT[\G_ /BJ/^%OZU_SX:=^
M3_\ Q5><%' )*. IP<J1@^])M;9OVMLSC=CC\Z ]M4[GI'_"W]:_Y\-._)__
M (JC_A;^M?\ /AIWY/\ _%5QF@:!>:XUP;5K>*&W4--/<2B.-,],GWJ2_P#"
M^K66H26;6IED2#[3OA.]&B_OAO2@:J56KIG7_P#"W]:_Y\-._)__ (JC_A;^
MM?\ /AIWY/\ _%5YN%8J6"MM'!;!P/QHVMY9?:VP=6QQ^= O;5.YZ1_PM_6O
M^?#3OR?_ .*H_P"%OZU_SX:=^3__ !5</K&CW>DW$4-T%9Y($N!Y1+ (W3/'
M%6O#_AJ[UNTNKFWN+*W@MF5)'NIO+ +=.<4#]I5O:YUW_"W]:_Y\-._)_P#X
MJC_A;^M?\^&G?D__ ,57$ZYH=]HM\+6[C5V9%D1X3YB.IZ$$=JJ7%HT,=LWF
M1R-.I8)&263G&&&.OTS0#JU%HV>@_P#"W]:_Y\-._)__ (JC_A;^M?\ /AIW
MY/\ _%5YQL<OL"/O_N[3G\J;TX/!H%[:IW/2?^%OZU_SX:=^3_\ Q5'_  M_
M6O\ GPT[\G_^*KS:B@/;3[GI/_"W]:_Y\-._)_\ XJC_ (6_K7_/AIWY/_\
M%5YM10'MI]STG_A;^M?\^&G?D_\ \51_PM_6O^?#3OR?_P"*KS:B@/;3[GI/
M_"W]:_Y\-._)_P#XJC_A;^M?\^&G?D__ ,57FU% >VGW/2?^%OZU_P ^&G?D
M_P#\51_PM_6O^?#3OR?_ .*KS:B@/;3[GI/_  M_6O\ GPT[\G_^*H_X6_K7
M_/AIWY/_ /%5YM10'MI]STG_ (6_K7_/AIWY/_\ %5V/PT\;7_BJ_OH+ZVM8
M5@B5U,(;)))'.2:\%KU#X"?\AG5O^O=/_0C0:4JLY32;(/CQ_P C/8?]>?\
M[.U>;5Z1\>"!XHT_/_/G_P"SM7FV1ZT&=;^(Q:*3(]:,CUH,A:*3(]:,CUH
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M\/\ SQC_ .^11]GA_P">,?\ WR*EHH B^SP_\\8_^^13TB2,Y1%7/H,4ZB@
MHJGK3;-(O&%S]DQ"W^D8SY7'WOPZUPFC/:1:5?6=_J%Y D<J22M#>M,)@S,
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M/_"C[#?_ /06F_[\Q_X5S%[K%WX;DN[%)Y]2^:%8)+A3*\;2;\JWEC<V F0
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M6"));K47>/<OG&[?S'1CDHS9R5]JD/AG3O[1BNU69/+*,(%E80ED&%8IT)
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MH'\NZMU)$1(QA\9^5NG3'':LJ1XIK/3;O7I-5M,&=8;FSA:+>K.,,ZH"R,P
M.. >?I76Z?KFF:KI-S>V\HDLX2Z3%T(QL^]D$5;TG4;;5M-M[ZQ<O;3KOC8J
M5)'T/(K38Y&9WA^YEGTJUM-7WF^E@9W21""T>[ +8& Q!&1UR37+ZM:?9_"W
MBN&WA>"-;Y3&(HONJ!%RH YQ@]!VKO-1O(=/L9[NZ8I!"A=V )P!["IT8.H9
M>C#(HOK<+:6/-M_VJ34I;*]U'5X_[,N(WFNK<Q^0< JJ81<ENXP3\HI]Q8W6
MER:!;V\$CZ9=7EM. BG_ $64#+@CLK=?8Y]:]!N+J&V:%9Y C3/Y48/\38)Q
M^0/Y5!JNIVFE0++>R%0[;$55+N[>BJ 23]*:D)QN8WB"R^W^*-&AF\\VHAG=
MUC=D5F!CV[BI'UQ7(Z"FKG6@S7C)J^Z4SPM;W!W##;0S%O*"_=P0/2O1=(U>
MSU:.1K-V+1-MDCD1HY(SUPRL 15^E>V@]SR>*!9[BR%@FJMJ9LKM;PSB7BX,
M0'5N V>FWC&*O7FI7>HQAM'&H[H]*V2$1.C;A(F\+D#+A=W]*]*JCI.J6VK6
M[SV1E:%7*!WB9 ^.ZY R/<<4[_U_7J%OZ_KT//[RVTF>WM9;&/5I-,M]2@<M
M-YNQ,@ABF?GQG;G/ /3O3E*F&S_X2(ZE_9>+C88C+GS_ #VQNV?-]W&W/'6O
M3**.8+'FL6FWFH0SMJ[:C]H@TA9(QYKH1(&D*LVTC+@!<_K72:E)<R>'=#D)
MF,[W%F92N0QRR[LX[=<UTU%*X6//-)L9;9M'U%7OC>3:G-#,7E=E\DM+A2I.
M O"D'%:?B[R_[:MO[5^W?V7]G;R?LOF?\?&[C.SG..F>.M=A11<9Y7IT5T-)
MLXVCN=BVFGG8RMPWVEMW'KC&:TTO9&DM=+=;[[4FLNTP\N0*(F:0J2_3:01C
MFO0:*?,38\=6VDMM)T^V4RVNG1/<+<B:.Y=1<;_E#>6P;[N,'[O7O6K=+(+:
MW7Q!-J=PGV#%G)!',A>;+YW*.=^W9C?VS[UZ;12OI8=M;F3X15D\+:2KJRL+
M6($,,$':.M:U5IKZ"&_M[.1B+BX5WC7:>0N,\_B*LT-W=P2LK'*Z]_R/WA3_
M *YWO_H"5U5<KKW_ "/WA3_KG>_^@)755E#XI>OZ([L5_"H_X7_Z7,****T.
M(**** "BBB@""^266SG2W\KSF0A/-7<F<<;AW%<UX1TK4+2"_P#M5O%912Y6
M*TCF,B*V6RXR!M!R  .PS7644 <7J7AZ]ETC2K>.T@EN(;46TD@O'@*?*!SM
M'[Q,]5/M3H] U&VD738$MWTMIX+AKEI")%\L)E=F.<E!SGC-=E13YF*P4444
MAA45W_QZS?[C?RJ6F7 W02 ]U(_2@<=T<?\ !U@WP[TK'8.#_P!]M79UQ?P>
M79X!L%'17E'Y2-7:5,/A1V9C_O=7_$_S"BBBJ.(*@OO^/&X_ZYM_*IZ@OO\
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MK#Z@]*@;4K=)UAE\R)WF,$8="/,;;N^7U&,\^U%PL>=00-]E_P")9;:K'?\
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MIAM*@[F)=@<X8_A7HUE9I=>&K2VM_M.FQ&)!LC7R9(P.J^JG]:S_ +;XP_Z
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M_P!M\8?] 31O_!F__P 9H^V^,/\ H":-_P"#-_\ XS1[97O9_<P^H3VYH_\
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MI;&V8E2,Y9@#R,UERV]U'O/%QQ"^M59KG49)KJV[I6^3_ [FBBBM3P0HHHH
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MT:'Q!H-YIEPQ59TP''5&'*G\"!4R5T=>"KJA7C.6W7T>_P"!J9&,YXZYK@_
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MT% #=Z?WE_.C>G]Y?SI2H./8YI<#T% #=Z?WE_.C>G]Y?SIV!Z"DVC=GVQ0
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MO4]&'YTM(% 8GUI: "BBB@ HHHH **** "BBB@ I&(526(  R2>U#,%4LQ
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M<_=P0_PQQ1KVX"@?TKGEU&SU>;3KJPM;B:6XAF$-QMPB1G@LQSC#%5P.O?%
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M'^ZHQTZDYSQUZ74)WLM/EEM[?SGC7Y(58)N]@3Q]*&"(=7UFRTE%:]E*;@6
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MH5FFHAA=(FQB_P!Y@I(#'W( )^M4;WQ/91M<V[/-;2Q2^1+(\?%N6'R2,#_
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MMD0H<>A&*S?#>A6^A67E1/)/.P7S;F7EY<# SZ #@ <"A,&C51510J *JC
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(0 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image00003.jpg
<TEXT>
begin 644 image00003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" "A G@# 2(  A$! Q$!_\0
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MKCP1_P!";X;_ /!7!_\ $UU5% '*_P#"N/!'_0F^&_\ P5P?_$T?\*X\$?\
M0F^&_P#P5P?_ !-=510!RO\ PKCP1_T)OAO_ ,%<'_Q-'_"N/!'_ $)OAO\
M\%<'_P 37544 <K_ ,*X\$?]";X;_P#!7!_\31_PKCP1_P!";X;_ /!7!_\
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MKCP1_P!";X;_ /!7!_\ $UU5% '*_P#"N/!'_0F^&_\ P5P?_$T?\*X\$?\
M0F^&_P#P5P?_ !-=510!RO\ PKCP1_T)OAO_ ,%<'_Q-'_"N/!'_ $)OAO\
M\%<'_P 37544 <K_ ,*X\$?]";X;_P#!7!_\31_PKCP1_P!";X;_ /!7!_\
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MKCP1_P!";X;_ /!7!_\ $UU5% '*_P#"N/!'_0F^&_\ P5P?_$T?\*X\$?\
M0F^&_P#P5P?_ !-=510!RO\ PKCP1_T)OAO_ ,%<'_Q-'_"N/!'_ $)OAO\
M\%<'_P 37544 <K_ ,*X\$?]";X;_P#!7!_\31_PKCP1_P!";X;_ /!7!_\
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MD>0ZY!]CBCD+!#+.,[&^7:5"-AF7!9?F !T'_"N/!'_0F^&__!7!_P#$T?\
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M@YSMYK"_X6"NGZ FOZG/!%;:U=^5H\-]*EG%'$$)5Y96&4#!2YR&(#* I/%
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MFZOHUIXBFUJZG\9:A>/$UO%]I\,W2B"(MN*+Y=HA(R!]\L>.O)SZ510!RO\
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MYXZ\GF@#(UKXUP:%XLU32-6T*18+6*:2&2TU&VNKB4Q)O8/;HQ:($ D%CZ9
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M= !1110 4444 %%%% !7*_$O_D7;/_L-:3_Z<;>NJKE?B7_R+MG_ -AK2?\
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MF"G<"NY@<CK@&O?:* "BBB@ KE?B7_R+MG_V&M)_].-O755ROQ+_ .1=L_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:R"11'G8 "5?ENAZ5M)XQM3JUIICV&H_;YK6&[E18<K;1R%AF1L@#:5(/?N
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MNV@AF)!QN48YHCB(2=D]2JV48JC%SFO=77Y7]?\ @EGXL?\ )+/&7_8%O/\
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M#_H1&/L?WON_[7Z5Z?10!R&J^##>V/B:"._$3ZQ<17*.8-P@:-(@H(W#>,Q
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M.W[46;=L'S?(F<9'.0,9Y-<[J_P\NQ<H+29+B"XO%,FV%8S#"9O.8N2Q\PY
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M&>:SM9\+:9J]^E[="^ANU01&6RU"XM&=0<A7\EUW@$G&[.,G'4T >>W/Q6U
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
HBB@ HHHH **** "BBB@ HHHH **** "BBB@!\/\ K4_WA1110!__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
